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 Abstract 
Viruses differ in their susceptibility and resistance to disinfectants and their ability to be 
inactivated based predominantly on structural and size differences.  The virucidal methodology 
followed in this study was consistent with the U.S. Environmental Protection Agency guidelines 
for such efficacy testing.  Various disinfectant chemistries were effective in rapid and complete 
inactivation of bovine coronavirus (BCV) including 25, 50, and 100% DF-200d,  10% bleach, 
1% Virkon® S, and 70% ethanol following 10 min treatments.  Efficacy was slightly reduced in 
the presence of organic challenge material (feces, soil).  Treatment with 100% DF-200d or 10% 
bleach resulted in the degradation of BCV RNA.  Treatment with 50 or 100% DF-200d, 10% 
bleach, or 1% Virkon® S resulted in the degradation of BCV proteins as detected by western blot 
analysis.  Various disinfectants were effective in the complete inactivation of both mammalian 
and avian influenza test strains and included DF-200d,  10% bleach, 1% Virkon® S, and 70% 
ethanol following 10 min exposure but was reduced in the presence of organic challenge.  
Treatment with DF-200d or 10% bleach resulted in significant degradation of influenza RNA.  
Effective treatments against foot-and-mouth disease virus (FMDV) and bovine enterovirus-2 
(BEV-2) included 10% bleach, 4% sodium carbonate, 2% sodium hydroxide, and Sandia DF-
200.  Treatment with 5% acetic acid was effective against FMDV, but not BEV-2.  Treatment 
with 70% ethanol was not effective for inactivating FMDV or BEV.  Additionally, 10 min 
treatment with 10% bleach, 2% sodium hydroxide, and Sandia DF-200 degraded FMDV and 
BEV-2 RNA.  FMDV inoculated surfaces were exposed to 5% acetic acid, 10% bleach, 70% 
ethanol, 4% sodium carbonate, 2% sodium hydroxide, Sandia DF-200, 0.4% Oxy-Sept® 333, or 
1% Virkon® S.  All treatments except 70% ethanol were effective following 10 and 20 min 
contact on rubber and stainless steel.  No treatments were shown to be effective for concrete, due 
to a low recovery of virus from this surface.  Additionally, 10 and 20 min treatments with 10% 
bleach, 2% sodium hydroxide, and Sandia DF-200 degraded FMDV RNA on the surfaces 
evaluated. 
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inactivated based predominantly on structural and size differences.  The virucidal methodology 
followed in this study was consistent with the U.S. Environmental Protection Agency guidelines 
for such efficacy testing.  Various disinfectant chemistries were effective in rapid and complete 
inactivation of bovine coronavirus (BCV) including 25, 50, and 100% DF-200d,  10% bleach, 
1% Virkon® S, and 70% ethanol following 10 min treatments.  Efficacy was slightly reduced in 
the presence of organic challenge material (feces, soil).  Treatment with 100% DF-200d or 10% 
bleach resulted in the degradation of BCV RNA.  Treatment with 50 or 100% DF-200d, 10% 
bleach, or 1% Virkon® S resulted in the degradation of BCV proteins as detected by western blot 
analysis.  Various disinfectants were effective in the complete inactivation of both mammalian 
and avian influenza test strains and included DF-200d,  10% bleach, 1% Virkon® S, and 70% 
ethanol following 10 min exposure but was reduced in the presence of organic challenge.  
Treatment with DF-200d or 10% bleach resulted in significant degradation of influenza RNA.  
Effective treatments against foot-and-mouth disease virus (FMDV) and bovine enterovirus-2 
(BEV-2) included 10% bleach, 4% sodium carbonate, 2% sodium hydroxide, and Sandia DF-
200.  Treatment with 5% acetic acid was effective against FMDV, but not BEV-2.  Treatment 
with 70% ethanol was not effective for inactivating FMDV or BEV.  Additionally, 10 min 
treatment with 10% bleach, 2% sodium hydroxide, and Sandia DF-200 degraded FMDV and 
BEV-2 RNA.  FMDV inoculated surfaces were exposed to 5% acetic acid, 10% bleach, 70% 
ethanol, 4% sodium carbonate, 2% sodium hydroxide, Sandia DF-200, 0.4% Oxy-Sept® 333, or 
1% Virkon® S.  All treatments except 70% ethanol were effective following 10 and 20 min 
contact on rubber and stainless steel.  No treatments were shown to be effective for concrete, due 
to a low recovery of virus from this surface.  Additionally, 10 and 20 min treatments with 10% 
bleach, 2% sodium hydroxide, and Sandia DF-200 degraded FMDV RNA on the surfaces 
evaluated. 
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CHAPTER 1 - Introduction to the Chemical Inactivation of Viruses 
Virucidal Methodologies 
Chemical disinfectants are an important component in disrupting the transmission of viral 
infectious disease and aiding in containment and eradication efforts.  While there is considerable 
published information and disinfection efficacy data regarding bacteria and fungi, the efficacy of 
chemical disinfectants against viruses has not been well studied.  Existing literature in the area of 
virucidal disinfectant efficacy is of limited value by virtue of the diverse testing methodologies 
used.   
Methodologies for evaluating disinfectants for virucidal efficacy exist both nationally and 
internationally in the form of guidelines and published standards, although these differ quite 
drastically.  Among these methodologies, the two predominant methods for evaluating virucidal 
efficacy of disinfectants are suspension and carrier tests.  Suspension tests evaluate the virus as 
liquid inoculum while carrier tests are designed for evaluating virus inoculated onto various 
surfaces.  Many disinfectants are assumed to be effective against viral targets without proper 
validation and simply on the basis of their performance against other microbial targets such as 
bacteria or other groups of viruses.   
Regardless of the inactivation method used, important considerations for evaluating 
virucidal activity of disinfectants should include the use of a representative test virus (ie. the 
specific virus or closely related virus) and the use of test protocols that mimic, as best as 
possible, the environmental conditions associated with anticipated use (58).  Validation of 
disinfectant efficacy can be more challenging than bactericidal testing, since assays such as virus 
enumeration and detection rely on the development and maintenance of a viable host cell system.  
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Because the testing procedure relies on a viable cell culture system, any toxicity from the 
chemical treatments must be adequately removed prior to infection with treated viral samples.     
To better understand the approach of existing national and international guidelines or 
standards on virus disinfection, it is important to understand some of the differences among virus 
groups with regard to their reaction to chemical disinfection.  Viruses are divided into several 
subgroups with regard to their resistance to disinfectants (Table 1), based largely on the presence 
or absence of an envelope and the size of the virus particle.  According to the Klein and Deforest 
schematic (47) for dividing viral groups, the least resistant to disinfectants are the enveloped 
viruses (ie. influenza, coronavirus);  those with moderate resistance are the large non-enveloped 
viruses (ie. adenovirus); and those with the most resistance are the small non-enveloped viruses 
(ie. picornavirus, parvovirus).  These subgroups of viruses are often termed category A, C, and 
B, respectively.  Category A and C are the least resistant, and disinfectants such as hypochlorite, 
alkalis, oxidizing agents, alcohols and aldehydes are all very effective in relatively short contact 
times (57).  Category B viruses are the most resistant viruses and great care must be taken to 
ensure complete inactivation. Because of these differences in resistance to disinfectants among 
the various groups of viruses, it is important to evaluate specific groups of a test virus (ie. 
enveloped versus non-enveloped) when establishing the efficacy of a particular disinfectant. 
A set of prescribed and standardized testing protocols for evaluating virucidal efficacy of 
disinfectants does not currently exist in the U.S.  However, national testing guidance can be 
found within the U.S. EPA (34) and the American Society for Testing and Materials (ASTM) (8-
11), as well as international sources (24), including the Association Francaise de Normalisation 
(AFNOR) in France and the Department of Environment , Food and Rural Affairs (DEFRA) in 
the United Kingdom.  Regardless of the testing protocol, most of the methods are described in 
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detail for either suspension tests, in which a liquid viral inoculum is evaluated, or carrier tests, in 
which virus is dried onto various surfaces and further treated with disinfectants.  All tests rely on 
adequate removal of toxicity from the chemical disinfectant to allow for post-treatment 
enumeration in an appropriate viable host cell system.  Many of these tests also consider 
additional organic challenge in the test protocols in order to better represent the disinfection 
environment that would be encountered in actual use.  Most protocols recommend the inclusion 
of 5-10% organic compounds (such as serum, feces, soil, etc) in the evaluation.   
Exposure length and virus recovery techniques are also described for infectious virus 
detection.  Exposure length is dependent on the chemical nature of the disinfectant.  In general, 
shorter exposure lengths are ideal, especially for surface disinfection on sensitive materials 
susceptible to corrosion effects from the disinfectants.  In most cases, virus detection and 
quantification is based on endpoint dilution assays in suitable assay systems as described in 
Fields Virology, Volume 1 (25).  Depending on the ratio of virus inoculum to disinfectant, the 
presence or absence of organic challenge, as well as the exposure time and method for toxicity 
removal, the reported ID50 values following disinfection can vary greatly between studies, 
making comparison difficult or sometimes impossible.  Such difficulties warrant the need for 
standardized efficacy testing procedures in the validation of virucidal compounds. 
Table 1.1 summarizes EPA guidelines, ASTM testing standards, and a few international 
standards available for evaluating the efficacy of chemical disinfectants using suspension and 
carrier-based methodologies.   The EPA published guidelines outline efficacy testing data 
requirements for the registration of virucidal disinfectants (34).  To summarize, these guidelines 
require that data be generated by generally recognized virological techniques which are 
technically sound and simulate as closely as possible the intended use and environment.  The 
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EPA guidelines further require that a disinfectant must be validated for each individual organism 
for which disinfection efficacy claims will be made.  Examples of accepted surrogate viruses in 
current EPA testing guidelines include duck hepatitis B virus for hepatitis B virus, bovine 
diarrhea virus for hepatitis C virus, feline calicivirus for norovirus (34, 83).  More recently, 
virucidal efficacy claims against avian influenza A could be applicable for efficacy claims 
against the highly pathogenic avian influenza H5N1 (4).  The Association of Analytical 
Communities (AOAC) Use-Dilution Method and the AOAC Germicidal Spray Products Test are 
both referenced by the EPA and require modification for virucidal testing, since these test 
procedures are developed predominantly for bacterial and fungal use (6).   
Under the EPA guidelines, virus recovery using endpoint dilution assay must include four 
replicate analyses for each dilution in the specific assay system (ie. cell culture, embryonated 
egg, animal infection).  The efficacy testing data package submitted to the EPA for chemical 
registration must include the following specific items: cytotoxicity controls; germicide activity 
(effectiveness); methods for increasing viral titer and/or removing residual germicide toxicity; 
initial infective dose-50 (ID-50) values; and reduction of ID-50 following treatment with test 
germicide expressed as log10 concentrations.  For EPA acceptance, the testing data must 
demonstrate complete inactivation of the virus at all dilutions, or if cytotoxicity is present, at 
least a 3-log reduction beyond the cytotoxic level (34). EPA guidelines further specify that the 
virucidal claim can only be made against entities actually tested.  Additional standards for 
evaluating the efficacy of biocides against viral agents are described by the American Society for 
Testing and Methods.   
There are several different international methods for evaluating virucidal activity, but 
there is no universal international standard or protocol (56).  Both the German DVV and the 
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French AFNOR agencies require 4 log reduction in virus titer, but there are discrepancies among 
the various protocols with regard to protein content, removal of chemical disinfectant, and 
concentration of disinfectant (15).  Most of the current accepted methods are limited by the 
selection of the test agent.  Both the DVV and AFNOR standards include Polio 1 as a test virus; 
however, this virus is presently restricted for use in research as a result of the ongoing poliovirus 
eradication effort of the World Health Organization.   
In the published literature, virucidal efficacy data is typically generated by quantitative 
assays for determining virus titer using generally recognized methods such as endpoint dilution 
(most commonly as TCID50).  The lack of standardized protocols makes data interpretation and 
comparison with other published testing results problematic.  For example, starting 
concentrations of viral inoculum often vary, so the amount of virus remaining following 
disinfection can vary drastically even with similar levels of total log reduction.  If a 4 log10 
reduction with an initial inoculum level of 9 log10 occurs, there are still 5 log10 remaining while if 
the starting level was 6 log10 of virus then only 2 log10 would remain.   
Many detection assays available for quantifying viral titers differ greatly in sensitivity, 
sometimes by several logs, and some assays such as nucleic acid amplification, do not directly 
measure loss of infectivity.  These assays also differ in what is used to confer diagnosis with 
regard to the structure and functionality of the virus.  Depending on the diagnostic test, different 
components of the virus are used for detection.  For example, endpoint assay is the ability of the 
virus to attach, enter, and replicate inside of a viable host culture system while an ELISA-based 
test requires the presence of a reactive epitope on the virus surface for a positive diagnosis.  
Nucleic acid amplification relies on successful extraction of nucleic material from the sample 
followed by a very specific polymerase chain reaction (PCR) or reverse transcriptase polymerase 
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chain reaction (RT-PCR) procedure for amplification.  With insensitive tests, a negative reaction 
could be misinterpreted as complete virus inactivation when in fact the test may not be capable 
of detecting the virus that is still present.     
Surrogate viruses are often necessary because of various factors including the inability to 
propagate a virus in a cell culture system or if working with a particular virus is difficult due to 
infectivity risk or other regulatory restrictions (84).  Surrogate test viruses are typically related to 
the virus family of interest, in an effort to maintain similar reactivity.  Fundamentally, surrogates 
are only a model system, and validation with the actual virus of interest should be conducted 
prior to making any specific claims regarding efficacy (58).  As mentioned previously, the EPA 
does not allow for surrogate virus testing in place of the disinfection claim, except for the non-
culturable viruses previously mentioned.  In this setting, surrogate testing might be advantageous 
for preliminary testing and optimization of a testing protocol prior to final testing against the 
viral target of interest. 
The mechanism of chemical inactivation against bacterial and fungal targets has been 
widely studied (43, 52, 53, 59).  Viruses are quite different than bacterial and fungal organisms 
with regard to more simplex structures (55, 57, 68, 75).  In general, the lipid envelope (if 
present), structural proteins such as the capsid or surface receptors, and the nucleic acid (DNA or 
RNA) can all be targets of attack by chemical biocides (75).  Inactivation can occur by 
degradation or disruption of any one of these or by all of them, depending on the chemistry of 
the disinfectant.  The following section includes information on several different groups of 
chemical disinfectants and includes hypothesized and tested theories for mechanism of virus 
inactivation.   
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Chemical Disinfectants 
Several groups of chemical disinfectants have been shown to have virucidal activity.  
Chemical disinfectant classes include the following groups: acids, alkalis, alcohols, surface 
active agents, phenols, oxidizing agents, and novel chemicals (75). Investigations of the 
mechanisms of virucidal activity by chemical agents are not widely published but hypotheses do 
exist (52, 53, 55, 57, 59).  The relative efficacy of disinfectants depends largely on whether or 
not the target virus is enveloped or non-enveloped.   
Acids 
Acetic acid (commonly referred to as vinegar) is a common disinfectant which shows 
efficacy against acid sensitive organisms most likely due to the undissociated molecule, H+ (43).  
(13).  Citric acid is described as a chelating agent that permeabilizes the outer membrane of 
lipophilic bacteria (62), and likely has virucidal activity against lipophilic (enveloped) viruses.  
High concentrations of citric acid are toxic and care should be taken when handling.  Citric acid 
can also be corrosive against metals and long exposure times should be avoided.  Citric acid is 
frequently recommended for decontamination of personnel and clothing material (7). Lactic acid 
is not as functional as a liquid disinfectant, but has shown efficacy as an air disinfectant 
functioning (43).  Peracetic acid (PAA) is rapidly becoming a popular disinfectant among the 
peroxygens class of disinfectant.  Peracetic acid is a fact-acting oxidizing agent that has been 
shown to be highly effective against bacteria, viruses, molds, yeasts, and bacterial spores (13, 
62).  This compound is active at relatively low concentrations, remains effective in the presence 
of organic material, and can be deployed as a liquid or vapor.  The active ingredient in PAA is 
speculated to be the generation of organic radicals such as CH3CO2 or CH3CO, which have 
shown greater longevity than the hydroxyl radical (20).   
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Alkalis 
Sodium hydroxide (NaOH) is an alkali with strong disinfectant properties, unless 
aluminum is present (13).  Due to the high pH of this compound, it is quite caustic to the eyes, 
skin, and mucous membranes (13) and should be handled with care and proper protective 
equipment.  NaOH is very inexpensive and is highly effective against viral targets in the 
presence of organic material, making this disinfectant suitable for use in an agricultural setting. 
Sodium carbonate (NaCO3) is another alkali disinfectant which is caustic to the eyes and 
skin and should be handled with care.  This disinfectant is described as being highly effective, 
even in the presence of organic material (7, 13).  Similarly, NaCO3 is also relatively low cost and 
is ideal for the agricultural setting. 
Alcohols 
At a 70% ethanol concentration, most enveloped viruses are readily inactivated, even in 
the presence of serum or other organic challenge.  Non-enveloped viruses, on the other hand, are 
very resistant to inactivation by ethanol.  The mechanism of inactivation by alcohol occurs by 
denaturing protein structure and inducing conformational changes; however the effects are 
dependent on concentration (53).   
Oxidizing Agents 
Sodium hypochlorite (household bleach) and N-chloro (organic chlorine) compounds are 
both oxidizing agents and frequently used for disinfection purposes.  These compounds are 
popular because of their broad range of applicability, low cost, and low toxicity to humans.  On 
the other hand, agents in this chemical class are irritants and corrosive to materials such as metal 
(13).  The stability of chlorine solutions is dependent on the following factors: concentration, 
presence of catalysts/reducing agents, pH, temperature, organic material, and ultraviolet radiation 
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(33).  Organic load and pH greatly reduces the effectiveness of chlorine disinfectants.  The 
optimum pH range for hypochlorite disinfectants is a pH value of 6-9.  
In general, the mechanism of action of chlorine based compounds begins with the 
disassociation of hypochlorous acid from the chlorine in solution.  Dissociated  hypochlorous 
acid has been speculated to interact with cell membranes thus altering metabolic processes, 
denaturing proteins, and the formation of toxic complexes (33).  These compounds have also 
been shown to oxidize thiol groups of cysteine residues which are important to structure 
determinants of proteins (53).  Chlorine disinfectants are affected by factors including pH, 
organic material, and light (71).  Chlorine is a corrosive disinfectant (71) and can result in the 
production of disinfection by-products (DBP) which include chloroform, bromodichloromethane, 
dibromochloromethane, and bromoform (33).    
Hydrogen peroxide, another oxidizing agent, generates free hydroxyl radicals which can 
break DNA (and RNA) structures (43).   Free hydroxyl radicals have been described as the 
strongest oxidants known, and can attack membrane lipids, DNA, and other essential cellular 
components (20).  These compounds have also been shown to oxidize thiol groups of cysteine 
residues which are important as structural determinants of proteins (53).  In the bacterial cell, this 
typically results in metabolic inhibition of the cell (53) while in viruses it likely produces a 
disruption in virus capsid structure.  The use of hydrogen peroxide results in few environmental 
side effects, since it breaks down into oxygen and water (62).  
Phenols 
Phenols bind to amino acid residues of cytoplasmic and membrane proteins that result in 
enzyme inhibition, membrane damage, and denaturation of cytoplasmic proteins (39, 43).  
Phenols are highly toxic, have a strong odor, and are irritants to skin and eyes (13).  Phenol 
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groups are effective against a wide variety of bacteria and often used as fungicides in the paper 
and cardboard industries.  Phenols cannot be used in food processing or with materials that will 
be used for food.  These groups of disinfectants are dated and not used as commonly in today’s 
disinfection practices (13).  In general, phenols are not very effective against non-enveloped 
viruses (39).   
Surface-active Agents  
Surface-active agents, also known as surfactants or quaternary ammonium compounds 
(QAC), are compounds comprised of a hydrophilic and a lipophilic portion (60).  Their mode of 
action against bacteria is largely described as cell membrane disruption and loss of potassium 
ions (60).  At present, little information is available on virus susceptibility to surfactant-based 
disinfectants.  Suspected mechanisms of action on viral systems include a primary effect on the 
lipid envelope with subsequent degradation of viral capsid proteins (58).  Viruses, specifically 
hydrophilic non-enveloped, are less susceptible to QACs than bacteria or fungi possibly due to a 
high amount of resistant structural protein (60).  Quaternary ammonium compounds remain 
active against lipophilic-enveloped viruses.  The mechanism of action of QACs involves protein 
denaturation and dissociation of enzymes (60) and interaction with lipids (53).  Both of these 
mechanisms could impact on both enveloped and non-enveloped viruses.   
Novel Chemistries  
Novel chemistries include a group of disinfectants which have been developed containing 
more than one active ingredient for a synergistic mechanism of action.  Many of these 
disinfectants have also been optimized for efficacy in the presence of organic material and for 
shorter contact times.  Oxy-Sept® 333 is an oxidizing disinfectant manufactured by Ecolab® 
with EPA registration (No. 1677-129) (2).  The active ingredient is peroxyacetic acid (5.8%, 
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undiluted) and hydrogen peroxide (27.5%, undiluted), as well as a surfactant.  Oxy-Sept® 333 is 
described as a stabilized peroxyacetic acid formulation tolerant, including water hardness, cold 
temperatures, and pH (2).   
Sandia Decon Foam-200 (Sandia DF-200) is a unique blend of quaternary ammonium 
compounds and peroxide for a synergistic mechanism of action that was developed at Sandia 
National Laboratories.  It is an aqueous-based disinfectant formulation which contains a cationic 
surfactant, buffers, a low concentration of hydrogen peroxide (<2% by weight), and a novel 
peroxide activator.  DF-200 formulation has been demonstrated to be  highly effective at 
neutralizing and/or killing chemical and biological warfare agents, and is in use by the U.S. 
military (91).  DF-200 is commercially available from EnviroFoam Technologies, Inc 
(www.envirofoam.com) and Modec, Inc. (www.deconsolutions.com).  The disinfection 
mechanism of DF-200 against viruses is most likely a result of the dual synergy between the 
surfactant oxidizing properties.  In addition to these chemistries, peracetate is also produced and 
further acts as a strong oxidizer.  Rapid degradation of capsid proteins and viral RNA has been 
observed in relatively short contact times (17, 18). 
Virkon® S is a powdered disinfectant manufactured by Antec International, Suffolk, UK 
(5).  The active ingredient in Virkon® S is potassium peroxymonosulfate, characterized as a 
strong oxidizing agent and a high level of surfactant (7).  This compound is toxic to the eyes, 
skin, and mucous membranes, and special care is required when handling.  A 1% solution of 
Virkon® S is recommended to disinfect walls, ceilings, floors, decks, container surfaces, 
vehicles, wheels, and other livestock equipment, although metal surfaces should not be exposed 
for more than 10 minutes due to its corrosiveness.  The recommended surface application level 
for Virkon® S is 300 ml/m2 (13).  
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Influential Factors Affecting Disinfection 
 Various environmental factors including temperature, humidity, pH, and organic 
load can all greatly impact the efficacy of disinfectants against viruses (15, 58, 59, 68, 71, 75).  
Warmer temperatures can increase the rate of the chemical reaction, but very high temperatures 
can affect the stability of the disinfection agent.  Cold temperatures will slow down chemical 
reactions, and very cold temperatures can freeze liquid based disinfectants.  Factors such as pH 
have the greatest impact on acidic- and alkaline-based disinfectants.  These disinfectants require 
specific pH ranges (acidic for the acid based disinfectants and basic for the alkaline compounds) 
and are sometimes affected by the presence of heavy organic soiling (68, 71). 
Other factors can come into play based on the intended application of the disinfecting 
agent.  Corrosive properties of some disinfectants can have undesirable effects on materials 
being treated.  The corrosion of metal surfaces that are treated with bleach is a primary example 
(71).  Exposure time of the disinfectant on sensitive surfaces or materials will also influence the 
degree of corrosion.  Furthermore, chemical disinfectants posses their own inherent stability 
properties and disinfectant product shelf life can also be an important issue.   
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Agency/ 
Organization 
Test Title Summary Reference 
US EPA Efficacy Data 
Requirements: 
Virucides 
Can be conducted as suspension or 
surface tests, minimum 104 test titer, 
must consider cytotoxicity 
(26) 
http://www.epa.gov  
ASTM E1052-96 Efficacy of 
Antimicrobial Agents 
Against Viruses in 
Suspension 
Method for evaluating efficacy of 
disinfectants against specific viruses 
in liquid suspension designed for cell 
culture host systems.  Includes cell 
culture control, virus control, 
virucidal test, cytotoxicity control, 
and neutralization control. 
(8) 
http://www.astm.org  
 
ASTM E1053-97 Efficacy of 
Virucidal Agents 
Intended for Inanimate 
Environmental Surfaces 
Method for evaluating disinfectants 
as liquid, aerosol, or trigger spray on 
inanimate surfaces.  Includes a cell 
culture control, virus control, 
virucidal test, cytotoxicity control, 
and a neutralization control. 
(9) 
http://www.astm.org 
 
ASTM E1482-04 
Neutralization of 
Virucidal Agents in 
Virucidal Efficacy 
Evaluations 
Method utilizes a gel filtration 
technology to separate the treated 
virus from the test disinfectant 
following the desired exposure 
duration.   
(1) 
http://www.astm.org 
 
ASTM E2197-02 Standard 
Quantitative Disk 
Carrier Test Method for 
Determining the 
Bactericidal, Virucidal, 
Fungicidal, 
Mycobactericidal and 
Sporicidal Activities of 
Liquid Chemical 
Germicides 
Method for evaluation liquid 
disinfectants for efficacy against 
various microbial targets in the 
presence of a soil load on disk 
carriers representing environmental 
surfaces or medical devices.  Test 
viruses include Human adenovirus, 
hepatitis A, Canine parvovirus, 
human rhinovirus, and human 
rotavirus. 
 (7) 
http://www.astm.org 
 
AFNOR Association Francaise 
de Normalisation 
Evaluates disinfectants at 2x 
concentration mixed to an equal 
volume of test virus (Polio 1*, 
Adenovirus, Vaccinia).  Organic 
challenge is not used, and virus is 
recovered by host culture following 
dilution and washing to remove 
cytotoxicity.  Efficacy claim must 
result in at least a 4 log10 reduction. 
(16) 
http://www.afnor.fr 
 
DVV Deutshe Verinigung zür 
Bekämpfung der 
Viruskrankheiten 
Evaluates disinfectants at final use 
concentration and includes challenge 
with BSA or FCS (0.2-10%) against 
test virus (Polio 1*, Adenovirus, 
Vaccinia, SV40).  Virus is recovered 
by host culture following dilution to 
remove cytotoxicity.  Efficacy claim 
must result in at least a 4 log10 
reduction. 
(24) Guidelines of 
Bundesgesundheit-
samt 
  
Table 1.1 Summary of National and International Virucidal Efficacy Standards    
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CHAPTER 2 - Inactivation and Mechanism of Action of Chemical 
Disinfectants against Coronavirus 
Abstract 
Viruses differ in their susceptibility and resistance to disinfectants and inactivation based 
predominantly on structural and size differences.  The virucidal methodology followed in this 
study was consistent with the U.S. Environmental Protection Agency guidelines for such efficacy 
testing.  We report that various disinfectant chemistries were effective in rapid and complete 
inactivation of bovine coronavirus (BCV) including 25, 50, and 100% DF-200d,  10% bleach, 
1% Virkon® S, and 70% ethanol.  Efficacy of all test disinfectants was slightly reduced in the 
presence of organic challenge material (feces, soil).  Additionally, the use of various diagnostic 
assays dependent on the intact presence of various viral structures (nucleic acid, protein).  
Treatment with 100% DF-200d or 10% bleach resulted in the degradation of BCV RNA.  
Treatment with 50 or 100% DF-200d, 10% bleach, or 1% Virkon® S resulted in the degradation 
of BCV proteins as observed by western blot analysis. 
Introduction 
Viruses are responsible for nearly 60% of human infections can have widespread disease 
occurrence and devastating economic impact to animal health (70).  In addition to vaccine and 
antiviral disease control strategies, chemical inactivation of viruses aid in the disruption of the 
infectious life cycle and disease transmission to aid in overall containment and control efforts 
(57, 75).  A more thorough and in depth understanding of both the efficacy and mechanism of 
action of different antiviral chemistries is necessary for effective disease control strategies.    
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Viruses, due to their simplicity, present limited targets for chemical mechanisms of 
inactivation.  These targets include the lipophilic envelope (if an enveloped virus), proteins 
(capsid, structural), and nucleic acid (RNA or DNA) (57, 67).  Viruses have been classified into 
three different groups to predict susceptibility to chemical disinfectants based on lipophilic 
properties and virus size (47, 67).  Group A viruses that have lipoprotein envelopes are the most 
susceptible to disinfectants.  Group B viruses are small, non-enveloped viruses that are the least 
susceptible to disinfectants.  Group C viruses are large, non-enveloped viruses which are 
intermediately susceptible to disinfectants.  In addition to the Klein and Deforest classification 
scheme, other factors including the infectious life cycle conditions of a particular virus (ie. 
enteric) can allow for resistance (to conditions such as acidity) to occur (70).  The Klein and 
Deforest classification is a predictive value but actual efficacy testing with specific compounds is 
necessary for proper validation measures.   
While there is considerable published information and disinfection efficacy data 
pertaining to bacteria and fungi, the efficacy of chemical disinfectants against viruses has not 
been well studied.  Disinfection is one of the leading measures for preventing infectious virus 
infections (57, 84).  Documentation of the effectiveness of viral disinfectants for emerging 
viruses is minimal, and is often assumed to occur based on existing bacteriological testing or 
without proper validation on specific viruses and in the presence of appropriate environmental 
conditions (84).  Published material is available in the general area of viral disinfection, but 
efficacy data on specific viruses or group of viruses isn’t readily available in existing literature 
and is difficult to interpret due to a lack of universal standardized virucidal testing procedures.  
Testing methodologies exist both nationally and internationally for evaluating disinfectant 
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efficacy against viruses in the form of guidelines or published standards but present considerable 
variability in test viruses required and in the degree of detail among these sources (16). 
In the U.S., the Environmental Protection Agency (EPA) provides guidelines for efficacy 
testing (34, 67).  The EPA guidelines require that a disinfectant must be validated for each 
individual organism it claims to be effective against.  It is unclear whether or not surrogate 
viruses are suitable for use in place of a closely related virus, or if the evaluation of one virus 
among a particular viral family can provide data useful for other viruses in the same family.  
Under the EPA testing guidelines, the disinfection evaluation can be conducted as suspension or 
surface carrier tests (based on the recommended use of the disinfectant) and the recovery of the 
virus must be obtained from a minimum of 4 determinations per each dilution assay system (74) 
(tissue culture, embryonated egg, animal infection infecting dose 50), and must result in 
complete inactivation of virus at all dilutions or at least a 3-log reduction in titer beyond the 
cytotoxic level (of the dilution assay system) (34).   
The purpose of this study was to evaluate the efficacy and mechanism of action of 
various chemical disinfectants against bovine coronavirus (BCV).  Disinfectant efficacy was 
determined following the EPA guidelines (34) with virus recovery using tissue culture infective 
dose 50 (TCID50) format.  To evaluate mechanism of inactivation of the disinfectant chemistries 
tested against BCV, reverse transcriptase polymerase chain reaction (RT-PCR) and protein 
identification assays were utilized to detect residual viral nucleic acid or protein, respectively.  
Chemical disinfectants used in this study included bleach, ethanol, Virkon® S (5), and DF-200d 
(91).  To determine the most effective disinfectants against BCV statistical analysis of the 
various disinfectant treatments were evaluated measuring the viral response (as measured by 
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TCID50 and quantitative BCV RNA concentration) to differences in time of exposure to the 
treatment, and the presence of different organic sample matrices.    
Materials and Methods  
Detection assays.  Analytical sensitivity was determined by evaluating various BCV 
diagnostic methods and included identifying BCV infectivity, BCV nucleic acid, and BCV 
protein using predetermined quantities of reference virus.  Endpoint titration (TCID50) for 
infectivity, RT-PCR for nucleic acid detection, and hemagglutination or electrophoresis/western 
blot analysis for protein detection were evaluated.  Assays resulting in the greatest analytical 
sensitivity for the detection of BCV were selected for further use in the disinfection efficacy and 
mechanism of action.   
BCV infectivity assay 
Virus and cells.  Bovine coronavirus isolate Wisconsin 1SK was propagated in Human 
Rectal Tumor-18 (HRT) cells as previously described (45).  Culture media was made by adding 
Minimal Essential Medium with Earle’s salts and L-glutamine (Invitrogen Corporation, 
Carlsbad, CA) and 2.2 g/L sodium bicarbonate collectively referred to as MEM with the addition 
of trypsin (5 µg/ml) and pancreatin  (5 µg/ml) (Fisher Scientific, Hampton, NH) (44).  Cells were 
maintained in MEM containing 10% fetal bovine serum (FBS, Hyclone Laboratories, Logan, 
UT) supplemented with antibiotics [2.5 mg/L amphotericin B; 0.67 g/L streptomycin; and 0.3 
g/L penicillin G (all from Fisher Scientific)].   
Tissue culture infective dose 50 (TCID50). To determine BCV infectious viral titers, 
tissue culture infective dose 50 (TCID50) were determined.  The Reed-Muench method (74) was 
calculated in a 96-well format to determine the dilution of virus resulting in infection of fewer 
than 50% replicate wells.  Nunc 96-well cell culture microtiter plates (Fisher Scientific) were 
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seeded with HRT cells and incubated (approximately 24 hrs, at 37oC with 5% CO2).   Once cells 
were monolayered, the media was removed and plates were washed once with 0.01 M phosphate 
buffered saline (PBS, pH 7.2).  Tissue culture-adapted BCV was then serially diluted (ten fold) 
in culture media to a 10-9 dilution.  The microtiter plates were inoculated by adding 25 µl of each 
virus dilution to each well.  Negative controls were inoculated with 25 µl of uninfected culture 
media.  An additional 75 µl culture media was added to each well and the plate was incubated 
(48 hrs, 37oC with 5% CO2).  Infectivity was determined by cytopathic effect (CPE) as indicated 
by the presence of large syncytial sloughing of infected cells and  TCID50 was calculated using 
the Reed-Muench method for estimating 50% endpoints of infectivity (74).     
BCV nucleic acid detection 
Real-time reverse transcription polymerase chain reaction (rRT-PCR). Viral RNA 
was recovered using the QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA).  Quantitative 
detection of the extracted BCV RNA was conducted using rRT-PCR using a fluorescently 
labeled TaqMan probe, and qualitative detection was visualized by agarose gel electrophoresis 
and Southern blot analysis.  A fluorescently labeled TaqMan probe was designed to be used with 
existing forward and reverse primers for the rRT-PCR amplification and detection of BCV RNA 
(90).  The TaqMan probe corresponded to the BCV nucleocapsid sequence (5´-TTT GGC ATG 
CGG TCC TGT TCC AAG AT-3’) and was synthesized and labeled (6-FAM™ at the 5´-end and 
Iowa Black Fluorescent Quencher at the 3’-end, Integrated DNA Technologies, Coralville, IA).  
For each 25 µl reaction, 2.5 µl of the RNA sample was added to 22.5 µl of master mix that 
contained 5 µl OneStep buffer, 1 µl dNTP, 1 µl enzyme (all from Qiagen’s OneStep RT-PCR 
kit), and 0.5 µl each of the forward and reverse primers (1 µM concentration), 2 µl probe (5 µM 
concentration), and 12.5 µl RNAse-free water.  The SmartCycler thermocycler was set with the 
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following settings: Stage 1 hold (42oC, 1800 s without optics), Stage 2 hold (95oC, 900 s without 
optics), Stage 3 was repeated 35 times using a 3-temperature cycle (94oC, 15 s without optics; 
58oC, 15 s without optics, and 72oC, 30 s with optics on).  The detection threshold for 
successfully detecting BCV RNA was a FAM fluorescence signal ≥ 3 using the SmartCycler.     
Analysis of rRT-PCR amplification products were completed by agarose gel 
electrophoresis.  Briefly, aliquots from rRT-PCR were loaded onto 1% agarose gels containing 
ethidium bromide and electrophoresed (90 V, 45 min).  A successful BCV rRT-PCR followed by 
electrophoresis and ethidium bromide staining results in the visualization of a 407 bp amplicon 
(90).  
Southern hybridizations were also completed on the rRT-PCR samples following 
electrophoresis.  The DIG System – Nonradioactive and Highly Sensitive Detection of Nucleic 
Acids (Roche Diagnostics, Indianapolis, IN) was used in our study and included all washing and 
blocking buffers required (49).  Gels were prepared for Southern hybridizations by washing in 
denaturing buffer for 30 min.  Denature buffer was removed, and gels were washed in 
neutralizing buffer for 30 min.  The DNA from the gel was transferred to a nylon membrane after 
these wash steps overnight and ultra violet (UV) cross-linked.  Following UV cross-linking, the 
DIG System protocol for colorimentric detection were completed (49).  The probe sequence used 
for the Southern hybridization was 5´- TTT GGC ATG CGG TCC TGT TCC AAG AT- 3´ 
labeled with digoxygenin (DigN) at the 3´ end.  A successful Southern blot of the BCV rRT-
PCR was interpreted as the visualization of a dark blue band of the 407 bp amplicon. 
Inhibition of rRT-PCR. To determine if reverse transcriptase (RT) or the subsequent 
PCR activity were inhibited by possible residual carry-over of chemical disinfectants in the 
extraction process, the test disinfectants were evaluated. The test disinfectants were prepared as 
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described and then the various chemistries were extracted using the QIAamp Viral RNA Mini 
Kit.  Following this extraction process (which didn’t have any RNA present) 1.25 µl from each 
of the extracted test disinfectants was inoculated with 1.25 µl of tissue culture derived extracted 
BCV RNA to obtain the total 2.5 µl volume required for the 25 µl reaction (described 
previously) to conduct the rRT-PCR amplification assay.  To determine if there was any 
carryover of residual disinfectant chemistry causing inhibition or interference of the rRT-PCR 
from any of the test disinfectants, a positive rRT-PCR (based on a FAM fluorescence signal ≥ 3 
using the SmartCycler) result was necessary.  A negative result would indicate that there was 
some residual disinfectant chemistry following the extraction process which inhibited or 
interfered with the rRT-PCR assay.     
BCV protein detection 
Hemagglutination activity. Hemagglutination activity (HA) of the samples as a 
correlation to amount of BCV present was also evaluated for determining BCV virus using 
rodent erythrocytes.  The microtiter method was used to detect BCV hemagglutinin activity 
using washed mouse erythrocytes in PBS (pH 7.2)  (85).  Virus was diluted 1:2 in 0.01 M PBS 
for a total volume of 100 µl in each well, and 100 µl of a 1:100 dilution of washed mouse 
erythrocytes was added to each well and the plates were incubated (30 min, 4oC).  The wells 
showing a lattice formation were recorded as a positive HA, while those with a button formation 
were recorded as negative HA.   
Electrophoresis and western blot. Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and western blot analysis was used to determine intact BCV 
structural proteins.  Viral samples were prepared for western blot analysis by adding 40 µl of 
each sample to 6 µl SDS 4x loading buffer (ISC BioExpress, Kaysville, UT) and mixing.  
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Samples were heat-denatured (boiled, 5 min) and 25 µl were loaded onto a 10% SDS- PAGE 
Express Gel (ISC BioExpress) and electrophoresed (80 min, 100 volts).  Following 
electrophoresis the gel was blotted to nitrocellulose membranes (60 min, 100 volts).  The 
nitrocellulose membrane was removed from the transfer apparatus and incubated (24 hours, 4oC) 
with 10% non-fat milk block (Bio-Rad, Hercules, CA).  A monoclonal antibody (8F2) (27) 
targeting the BCV nucleocapsid protein was added at a 1:100 dilution to the 10% non-fat milk 
block and incubated (60 min, room temp).  The membrane was washed (3 times, 10 min each) in 
PBS containing 0.05% Tween 20 (PBS/Tween).  A horse radish peroxidase-labeled secondary 
anti-mouse antibody (KPL, MA) was added at a 1:10,000 dilution in PBS/Tween and was 
incubated (60 min, room temp).  The membrane was washed as previously described.   The 
presence of intact or residual BCV nucleoprotein was determined by colorimetric detection by 
adding 20 ml SureBlue™ TMB Peroxidase Substrate solution (Kirkegaard and Perry 
Laboratories, Gaithersburg, MD) and the subsequent visualization of blue bands of a 50-60 kDa 
nucleocapsid protein (50).  
Disinfectant efficacy testing 
Test disinfectants.  Ethanol was prepared by adding 70 ml 100% anhydrous ethanol 
(Fisher Scientific) to 30 ml sterile deionized water for a final use concentration of 70%.  Bleach 
was prepared by adding 10 ml concentrated house hold bleach to 90 ml sterile deionized water 
for a final concentration of 10%.  DF-200d, a reduced concentration of Sandia DF-200 (91), was 
supplied by Sandia National Laboratories (Albuquerque, NM) and was prepared by mixing 7.3 
ml of part 1 (surfactants and fatty acids) to 0.2 ml part 3 (a diacetin-based propellant).  Finally, 
2.5 ml of part 2 (hydrogen peroxide, 7.99%) was added and the mixture was thoroughly mixed to 
yield the 100% test concentration of DF-200d.  The 100% DF-200 was serially diluted (two-fold 
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dilutions) in deionized water to obtain the 50% and 25% test concentrations.  Virkon® S was 
purchased from the DuPont Animal Health Solutions (Antec®, Suffolk, UK) and diluted to 1% 
by adding 0.1 g to 10 ml deionized water.     
Organic matrices. The organic matrices used in this study included a 10% 
weight/volume (wt/vol) solution of bovine feces and a 10% wt/vol solution of soil.  The bovine 
feces were prepared by rectally collecting fecal material from healthy cattle, weighing out 10 g 
of the feces, and adding 90 ml 0.01 M PBS and mixing thoroughly.  The soil used in this study 
was provided by the Soil Testing Laboratory (Department of Agronomy, Kansas State 
University, Manhattan, KS) and was prepared by removing most of the plant/root material via a 
sifting process.  Soil (10 g) was then added to 90 ml of 0.01 M PBS and mixed thoroughly.   
Virus inactivation. Ten milliliters of tissue culture propagated BCV (approximately 106-
7 log10 TCID50/ml) was added to 10 ml test disinfectant (25, 50, and 100% DF200d, 1 and 10% 
bleach, 1% Virkon® S, 70% ethanol) and were incubated (1 and 10 min, room temperature).  For 
each organic challenge, 10 ml of test virus was added to 9 ml of test disinfectants containing 1 
ml of a 10% bovine fecal slurry or 10% soil slurry and were incubated (1 and 10 min, room 
temperature).  Resulting samples were washed by ultracentrifugation (100,000xg, 1 hour, 4oC) 
and pellets were reconstituted with 1 ml of MEM and stored at -80oC.   
Post-treatment infectivity determination.  The titers of infectious virus were 
determined by TCID50 as previously described.  Nunc 96-well plates containing confluent HRT 
monolayers were washed once with MEM.  Wells were filled with 25 µl of each disinfectant 
sample and their dilutions.  Then, 75 µl media were added to each well and plates were incubated 
(24-48 hours, 37oC, 5% CO2).  The TCID50 was evaluated by visual CPE and calculated using 
the Reed-Muench method for estimating 50% endpoints of infectivity.     
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Post-treatment RNA determination. Viral BCV RNA was recovered from the test 
samples following 1 or 10 min treatments with each test disinfectant using the QIAamp Viral 
RNA Mini Kit, as previously described.  Quantitative detection of BCV RNA was determined by 
rRT-PCR and qualitative detection was visualized by electrophoresis/ethidium bromide staining 
or Southern blot hybridization assay as previously described.   
Post-treatment protein recovery.  The effect of the various test disinfectants on the 
ability to detect BCV nucleocapsid proteins was determined by western blot analysis of the 
samples treated with each disinfectant using a monoclonal antibody (8F2) with specificity for the 
nucleocapsid protein.  Disinfectant samples were prepared for SDS-PAGE and western blot 
analysis as previously described.   
Statistical analysis. Statistical evaluation comparing of the level of BCV recovered (for 
infectivity by TCID50 or for RNA by quantitative rRT-PCR) following the experimental 
treatment parameters was determined by comparing 1-way, 2-way, and 3-way interactions 
between disinfectant treatment, time (1, 10 min), and organic challenge (no organic, 10% soil, 
10% feces).  The least square of means was calculated to determine if significant differences 
were observed in the untreated (positive control) amount of BCV recovered compared to the 
level of BCV recovered post treatment.  A significant difference resulted in a P-value < 0.05.   
Results 
Detection assay.  The analytical sensitivity of the various diagnostic BCV assays were 
evaluated and included virus isolation of infectious BCV as assessed by endpoint dilution 
(TCID50), specific amplification of BCV RNA by RT-PCR (detected by TaqMan probe, ethidium 
bromide, or Southern blot hybridizations), and detection of BCV proteins (HA analysis of BCV 
hemagglutinin esterase structural protein and western blot analysis of BCV nucleocapsid protein) 
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(Table 2.1).  Detection of BCV RNA using the rRT-PCR assay as detected using a TaqMan 
probe was the most sensitive assay detecting 102 TCID50/ml BCV.  Infectivity titration based on 
endpoint dilution (TCID50) in HRT cells resulted in a detection sensitivity of 103 TCID50/ml 
BCV.  The RT-PCR product as detected by ethidium bromide staining and Southern blot analysis 
resulted in a detection sensitivity of 104 TCID50/ml BCV.  Detection of BCV hemagglutinin 
resulted in a detection sensitivity of 106 TCID50/ml BCV while detection of BCV nucleoprotein 
using western blot analysis with the monoclonal antibody (8F2) resulted in detection sensitivity 
of 105 TCID50/ml BCV.   
The most sensitive detection assays (Table 2.1) were selected for a quantitative recovery 
of BCV virus post disinfectant treatment to evaluate the disinfectant efficacy.  These assays 
included the infectivity titration of BCV based on endpoint dilution (TCID50) in HRT cells and 
detection of BCV RNA using rRT-PCR as detected using a TaqMan probe.   Although not 
quantitative, detection of BCV nucleoprotein using western blot analysis with the monoclonal 
antibody (8F2) was selected as a qualitative recovery of BCV protein following disinfectant 
treatments.    
Post-treatment infectivity determination.  No significant 3-way interactions were 
observed between disinfectant treatment, time, or organic challenge (P > 0.05).  The exposure 
time and organic challenge parameters resulted in a significant 2-way interaction (P < 0.05).  
Challenge with 10% feces resulted in a greater loss of disinfectant efficacy than challenge with 
10% soil following 1 min treatment, however these organic challenge effects resulted in no 
significant difference following 10 min treatment.  Without the addition of organic challenge, 
there were no significant differences between the 1 or 10 min exposure times in the amount of 
BCV recovered.  However, the addition of 10% soil or 10% feces challenge resulted in 
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significantly reducing the efficacy of all test disinfectants following 1 min compared to treatment 
with 10 min based on the amount of infectious BCV recovered post-treatment (P < 0.05).   
The amount of untreated (positive control) BCV ranged between 6.64 to 8.85 log10 
TCID50/ml for all organic challenge matrices (0%, 10% soil, 10% feces) evaluated.  The addition 
of 10% soil or 10% feces reduced the efficacy of all test disinfectants for both 1 and 10 min 
treatments (Figures 2.1 and 2.2).  All test disinfectants resulted in a significant reduction in the 
amount of BCV recovered following 1 and 10 min treatments when compared to the positive 
control (P < 0.05).  There were three categories of significant differences observed among the 
test disinfectants with regard to the level and extent of inactivation.  Overall, 100% DF-200 and 
10% bleach were consistently the most effective treatments.  The next most effective grouping of 
disinfectant treatments was 25% and 50% DF-200 and 1% Virkon S.  The least effective 
grouping of disinfectant treatments was 1% bleach and 70% ethanol.     
Treatments for 1 min without organic challenge using 100% DF-200 or 10% bleach 
resulted in the complete inactivation of BCV, to the detection limit of this assay (103 TCID50/ml 
BCV) (Figure 2.1).  The addition of 10% soil or 10% feces reduced the efficacy of these 
disinfectants and resulted in the recovery of 0.86 to 4.10 log10 TCID50/ml BCV.  Treatment for 1 
min without organic challenge using 25% DF-200, 50% DF-200 or 1% Virkon S resulted in the 
recovery of 0.57 to 1.44 log10 TCID50/ml BCV (Figure 1). The addition of 10% soil or 10% feces 
reduced the efficacy of these disinfectants and resulted in the recovery of 2.32 to 5.43 log10 
TCID50/ml BCV.  Treatments for 1 min without organic challenge using 1% bleach or 70% 
ethanol resulted in the recovery of 1.3 to 1.64 log10 TCID50/ml BCV (Figure 2.1). The addition of 
10% soil or 10% feces reduced the efficacy of these disinfectants and resulted in the recovery of 
4.68 to 6.43 log10 TCID50/ml BCV.       
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Treatments for 10 min without organic challenge using 25%, 50%, and 100% DF-200, 
1% Virkon S and 10% bleach resulted in the complete inactivation of BCV, to the detection limit 
of this assay (103 TCID50/ml BCV) (Figure 2.2).  The addition of 10% soil or 10% feces reduced 
the efficacy of these disinfectants and resulted in the recovery of 0.70 to 3.76 log10 TCID50/ml 
BCV.  Treatments for 10 min without organic challenge using 1% bleach or 70% ethanol 
resulted in the recovery of 1.64 to 1.97 log10 TCID50/ml BCV (Figure 2.2). The addition of 10% 
soil or 10% feces reduced the efficacy of these disinfectants and resulted in the recovery of 1.86 
to 4.10 log10 TCID50/ml BCV.             
Post-treatment RNA determination. Inhibition of the rRT-PCR assay was evaluated to 
verify that carry-over of test disinfectant chemistries was not interfering or inhibiting the rRT-
PCR reaction.  Inhibition of rRT-PCR did not occur for any of the test disinfectants used in this 
study based on a positive reaction occurring after inoculating the extracted disinfectant samples 
with purified BCV RNA (based on a FAM fluorescence signal ≥ 3 using the SmartCycler).  
Based on the demonstration of no interference or inhibition occurring with any of the test 
disinfectants, any reduction in the amount of BCV RNA recovered post-treatment is due to the 
mechanism of the disinfectant degrading the nucleic acid as opposed to chemical interference or 
inhibition of the rRT-PCR assay reaction.  
There were no significant 3-way interactions observed between disinfectant treatment, 
time, or organic challenge (P > 0.05) in the amount of BCV RNA recovered by rRT-PCR.  
Disinfectant treatment and exposure time resulted in a significant 2-way interaction (P < 0.05).  
Challenge with 10% feces resulted in a greater loss of efficacy than challenge with 10% soil 
when compared to treatment without organic challenge for both time exposures.  Organic 
challenge with 10% soil was not significantly different when compared to treatment without the 
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addition of organic challenge (P > 0.05).  There were also no significant differences observed in 
the amount of BCV RNA recovered post-treatment between 1 or 10 min exposure except with 
treatments using 50% DF-200 and 1% Virkon S (P < 0.05).   
The amount of untreated (positive control) BCV RNA units recovered ranged between 
6.47 to 7.42 log10 based on a known starting amount of cell-culture derived BCV (titrated as 
log10 TCID50/ml) and was calculated as the fluorescence intensity of the FAM reporter divided 
by the Ct (cycle threshold) value (RNA FAM/Ct).  The efficacy of all test disinfectants for both 1 
and 10 min treatments was significantly reduced by the addition of 10% feces (P < 0.05), but not 
with the addition of the 10% soil (P > 0/05), (Figures 2.3 and 2.4).     
Treatment with 100% DF-200 and 10% bleach were the most effective in RNA 
degradation resulting in complete degradation (0% organic or 10% soil) and significant from the 
remaining treatments, P < 0.05, (Figure 2.3).  The addition of the 10% feces reduced the efficacy 
resulting in the recovery of 1.08 to 2.58 log10 RNA FAM/Ct.  The next most effective treatment 
was with 50% DF-200, resulting in the recovery of 0.91 and 2.97 log10 RNA FAM/Ct with 0% 
organic or 10% soil challenge, respectively.  The addition of the 10% feces reduced the efficacy 
resulting in the recovery of 4.76 log10 RNA FAM/Ct.  Treatment with 25% DF-200 resulted in 
the recovery of 4.62-5.43 log10 RNA FAM/Ct with all organic challenges evaluated.  The least 
effective treatments included 1% bleach, 1% Virkon S, and 70% ethanol resulting in the recovery 
of 6.11 to 7.30 log10 RNA FAM/Ct with all organic challenges evaluated.   
Treatment with 50% DF-200, 100% DF-200 and 10% bleach were the most effective in 
RNA degradation resulting complete degradation (0% organic or 10% soil) and significant from 
the remaining treatments, P < 0.05, (Figure 2.4).  The addition of the 10% feces reduced the 
efficacy resulting in the recovery of 1.11 to 2.31 log10 RNA FAM/Ct.  The second most effective 
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treatments were 25% DF-200 and 1% Virkon S resulting in the recovery of 2.79 to 5.66 log10 
RNA FAM/Ct with all organic challenges evaluated.  The least effective treatments were 1% 
bleach and 70% ethanol resulting in the recovery of 4.05 to 7.10 log10 RNA FAM/Ct with all 
organic challenges evaluated and were not significantly different from the amount of BCV RNA 
recovered from the untreated positive control, P > 0 .05.    
Post-treatment protein recovery. Following a 1 min exposure and western blot using 
the monoclonal 8F2 antibody (Figure 2.5), treatment with 50% DF-200d, 100% DF-200d and 
10% bleach completely degraded BCV nucleoprotein (based on a negative presence of the 
appropriate band).  BCV protein was still recovered from samples treated with 25% DF-200d, 
1% bleach, 1% Virkon® S, and 70% ethanol.  Following a 10 min exposure, 50-100% DF-200, 
10% bleach, and 1% Virkon® S completely degraded BCV nucleoprotein.  BCV nucleoprotein 
was still recovered from samples treated with 25% DF-200d, 1% bleach, and 70% ethanol.  A 3 
min time exposure was also conducted and resulted in the same recovery results as with the 10 
min exposure, indicating that the 1% Virkon® S required at least a 3 minute contact to degrade 
this viral protein.   
Discussion 
In order to increase the understanding of the virucidal efficacy and mechanism of action 
of various disinfectant chemistries, we evaluated the chemical inactivation of various chemical 
treatments against BCV based on infectivity assays to be compliant with the current EPA 
virucidal testing guidelines as well as other detection assays.  Disinfectant efficacy was 
determined following the EPA guidelines (34) with exposure at two times (1 or 10 min) with 
virus recovery using TCID50 format.  To represent possible environmental or less than ideal 
conditions, we included two types of organic challenge with soil or fecal material.  The 1 min 
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treatments with 25, 50, and 100% DF-200d, 10% bleach, 1% Virkon® S, and 70% ethanol all 
resulted in the complete inactivation of BCV.  These treatments were all affected by the presence 
of both organic challenges consisting of 10% soil or 10% feces.  Additional molecular and 
serological assays were included to evaluate the possible mechanism of action of the test 
disinfectants against virus targets such as the nucleic acid or protein.  Treatment with 100% DF-
200d or 10% bleach resulted in the degradation of BCV RNA.  Treatment with 50 or 100% DF-
200d, 10% bleach, or 1% Virkon® S resulted in the degradation of BCV proteins as detected by 
western blot analysis.   
The enveloped (category A) viruses are likely the least resistant due to relatively easy 
degradation and breakdown of the unstable lipid envelope rendering the virus particles 
replication defective, due to the compromised attachment and entry processes.  Following 
disruption of the lipid envelope (which likely results in complete inactivation), the nucleocapsid 
protein of the virus is exposed and remains susceptible to the activity of chemical denaturants 
including quaternary ammonium compounds (QAC), chlorine compounds, phenols, acids, bases, 
and some alcohols (67).  The viral RNA also becomes susceptible to the activity of nucleic acid 
denaturants, including various oxidants, acids, and bases (67).      
The preliminary evaluation of various detection assays for the recovery of BCV was 
important to determine the most sensitive assays for detecting how much BCV is present in a 
sample.  Although not required within the EPA guidelines for virucidal testing, it is helpful to 
understand the limitations with regard to test sensitivity of diagnostic assays, especially when 
trying to determine if a reduction in titer has occurred.  We found endpoint dilution using TCID50 
and quantitative rRT-PCR using fluorescent detection to be the most sensitive assays for 
detecting BCV.  The greatest challenge for both of these assays to be used for virucidal testing 
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was the potential for chemical carry-over inducing cytotoxicity issues in the infectivity assay (16, 
34, 67) or inhibition or interference of the rRT-PCR assay resulting in a possible false negative.  
We showed that none of the test disinfectants used in our evaluation resulted in either 
cytotoxicity of the cell culture recovery process (TCID50) or in the inhibition or interference of 
the rRT-PCR assay.  The addition of an ultracentrifugation step in our methodology to purify the 
virus and remove the chemical component of the samples resulted in the removal of cytotoxicity 
for most disinfectants evaluated (except for DF-200d and Virkon S).  The use of gel filtration in 
special centrifuge tubes has also been shown to be effective for the adequate removal of 
chemical disinfectants and cytotoxicity concerns (79).  Although the DF-200d and Virkon S were 
cytotoxic even post-ultracentrifugation, all dilutions beyond the first serial 1:10 dilution for both 
of these disinfectants were non-cytotoxic and met the requirements of the EPA guidelines 
“showing a minimum of a 3-log reduction in titer beyond the cytotoxic level” (34).   
The RNA recovery procedure used in the experiments adequately removed detectable 
residual RT-PCR inhibitory chemicals.  Within the current EPA testing guidelines, the RNA 
recovery procedure validation process is not included as a necessary requirement to determine if 
inhibitory chemicals are present because infectious titer recovery is the recommended procedure.  
Because some viruses such as the noroviruses (31, 32) are not able to be cultivated in a host 
system, the use of molecular or serological assays for virus recovery would have to be used and 
such preliminary validation would be very important to ensure that inhibition or interference is 
not occurring.      
We showed that the amount of BCV recovered using TCID50 demonstrated similar 
efficacy of each test disinfectant for both time exposures (1 or 10 min) in the absence of organic 
challenge.  This relatively short and efficacious contact time for an enveloped virus is consistent 
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with the Klein and Deforest scheme predicting virus susceptibility to chemical inactivation (47).  
Other work comparing the efficacy of feline viruses resulted in similar conclusions showing 
greater susceptibility of enveloped viruses against chemical disinfectants when compared to non-
enveloped test strains after a 10 min exposure (79).  In separate inactivation research efforts 
conducted using the Severe Acute Respiratory Syndrome (SARS) virus, also a coronavirus, the 
virus was found to be sensitive to many chemical treatments resulting in loss of infectivity (28, 
73, 92).  In one study, chemical treatments with pH conditions of 1 and 3 or 12 and 14 were 
shown to completely inactivate the SARS virus at 25 and 37oC for 1 h, however formaldehyde 
and glutaraldehyde at 1:1000 were found to be effective only after 2-3 days (28).  In another 
experiment, the SARS virus was reported to be inactivated by various fixative procedures 
including 2-isopropanol (70%), Sterillium (45% 2-propanol, 30% 1-propanol), formaldehyde 
(0.7 and 1%), or glutardaldehyde (0.5%) (73), however the total reduction in titer for most of 
these was not greater than the 4 log10 infectious titer reduction required in the EPA virucidal 
guidelines.  In a third example, free residue chlorine over 0.5 mg/L for chlorine or 2.19 mg/L for 
chlorine dioxide were shown to effectively inactivate the SARS virus following a 30 min 
exposure (92).  Most of these experiments were conducted in ideal conditions without the 
addition of any environmental or organic substrates to challenge the efficacy parameters.  
 In the presence of two organic challenge matrices (10% soil and feces) used in our 
evaluation to represent environmental or less than ideal conditions, the virucidal efficacy was 
reduced in all test disinfectants used.  This observed reduction is consistent with current 
literature suggesting that the presence of organic material likely disrupts the mechanism and 
efficacy of chemical disinfectants by directly neutralizing the reaction or by serving as a 
protective barrier disrupting the penetration to the virus particle (57, 67, 76).  The current EPA 
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guidelines for conducting virucidal efficacy testing do not require the addition of any organic 
challenge even though it is likely that most chemical disinfectants will be negatively affected in 
their presence and should be included to enhance the overall evaluation.   
The amount of BCV RNA recovered post-treatment with the test disinfectants evaluated 
in the absence of organic challenge did not vary significantly whether exposed for short contact 
(1 min) or long contact (10 min), indicating that any mechanism occurring was fairly rapid.  Not 
all test disinfectants evaluated in this study degraded nucleic acid.  Treatment with 100% DF-
200d or with 10% bleach resulted in the greatest amount of BCV RNA degradation.  This is 
likely due to the presence of strong oxidizing agents (hydrogen peroxide in DF-200d or 
dissociated hypochlorous acid in bleach) which have both been shown to degrade nucleic acid 
(20, 33).  Treatment with 25% or 50% DF-200d also resulted in some degradation of BCV RNA, 
but not as much as observed with the full strength 100% DF-200d, probably due to the dilution 
of the oxidizing agent.  Treatments which did not appear to degrade BCV RNA at all included 
1% bleach, 1% Virkon S, and 70% ethanol.  The 1% bleach most likely did not degrade BCV 
RNA due to the reduced concentration of the reactive dissociated hypochlorous acid, as was 
observed with the reduced concentrations of DF-200d.  Potassium peroxymonosulfate is the 
active ingredient in 1% Virkon S and is also an oxidizing agent.  It is not fully understood why 
this treatment didn’t degrade the BCV RNA, but could be due to the highly acidic nature of this 
chemistry (ca. 2.0) (5, 52, 57).  Viral inactivation has been described as fully occurring when the 
viral nucleic acid has been rendered non-infectious (52), especially in the case of a positive sense 
RNA genome such as that of the coronavirus.  Although it might be unlikely for RNA to remain 
infectious in the environment, it is useful to understand the mechanism of action against the 
limited viral targets (envelope, protein, nucleic acid) as such diagnostic assays based on the 
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intact presence of these targets could be designed for more rapid determination of viral 
inactivation.   
The recovery of infectious BCV in this study was based on endpoint titration (TCID50) in 
HRT cells and resulted in a greater than 4 log10 reduction in titer by the Sandia National 
Laboratories DF-200d (25, 50, 100%), 10% bleach, and 1% Virkon® S following 1 min 
exposure.  Based on the EPA guidelines and criteria for determining virucidal efficacy (34), 
these disinfectants show complete inactivation meet the criteria for making virucidal claims 
against BCV.  It is likely that these disinfectants would also be effective against the closely 
related SARS virus based on existing reports using surrogate viruses (84).   
In conclusion, we report that various disinfectant chemistries were effective in rapid and 
complete inactivation of BCV including 10% bleach, 25, 50, and 100% DF-200d, and 1% 
Virkon® S.  Efficacy of all test disinfectants evaluated was reduced in the presence of organic 
challenge material (feces, soil).  The virucidal methodology followed in this study was consistent 
with the US EPA guidelines for such efficacy testing.  Additionally, the use of various diagnostic 
assays dependent on the intact presence of various viral structures (nucleic acid, protein) 
provided useful data on possible mechanism of action of the chemical disinfectants evaluated in 
this study.   
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Figure 2.1 Infectivity of BCV as measured by TCID50 following 1 min exposure to test 
disinfectants in the presence of no organic challenge, 10% soil, and 10% feces.   
 
Error bars indicate 1 standard deviation (n = 3).   CONT, control sample using 0.01 M PBS in 
place of disinfectant; DF, DF-200d; BLCH, bleach; VIRKON, Virkon® S; ETOH, ethanol. 
 
 
 
 
 
 
 
 
 
 34
01
2
3
4
5
6
7
8
9
10
CONT 100% DF 50% DF 25% DF 10%BLCH 1%BLCH 1%VIRKON 70%ETOH
lo
g 1
0 
TC
ID
50
/m
l
0% Organic
10% Soil
10% Feces
 
Figure 2.2 Infectivity of BCV as measured by TCID50 following 10 min exposure to test 
disinfectants in the presence of no organic challenge, 10% soil, and 10% feces.   
 
Error bars indicate 1 standard deviation (n = 3).   CONT, control sample using 0.01 M PBS in 
place of disinfectant; DF, DF-200d; BLCH, bleach; VIRKON, Virkon® S; ETOH, ethanol. 
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Figure 2.3 Quantitative rRT-PCR following 1 min exposure to test disinfectants in the presence 
of no organic challenge, 10% soil, or 10% feces.   
 
Error bars indicate 1 standard deviation (n = 3).   CONT, control sample using 0.01 M PBS in 
place of disinfectant; DF, DF-200d; BLCH, bleach; VIRKON, Virkon® S; ETOH, ethanol. 
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Figure 2.4 Quantitative rRT-PCR following 10 min exposure to test disinfectants in the presence 
of no organic challenge, 10% soil, or 10% feces.   
 
Error bars indicate 1 standard deviation (n = 3).   CONT, control sample using 0.01 M PBS in 
place of disinfectant; DF, DF-200d; BLCH, bleach; VIRKON, Virkon® S; ETOH, ethanol. 
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Figure 2.5 Western blot analysis of BCV virus following various treatments with test 
disinfectants based on the monoclonal 8F2 antibody targeting the nucleocapsid protein.   
 
Samples were treated for 1 min (A) or 10 min (B).  Sample order is as follows: 1. 50 kDa protein 
marker, 2. positive control (BCV); 3. 100% DF-200d; 4. 50% DF-200d; 5. 25% DF-200d; 6. 
10% bleach; 7. 1% bleach; 8. 1% Virkon® S; 9. 70% EtOH. 
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 BCV 
Conca 
Infectivity          Nucleic Acid Protein 
Log Titer TCID50b EtBrc SYB
Rd 
Southerne Probef 8F2 
Mabg 
HAh 
1.00E+06 (3/3) (3/3) (3/3) (3/3) (3/3) (3/3) (3/3) 
1.00E+05 (3/3) (3/3) (3/3) (3/3) (3/3) (3/3) (1/3) 
1.00E+04 (3/3) (3/3) (3/3) (3/3) (3/3) (0/3) (0/3) 
1.00E+03 (3/3)i (0/3) (0/3) (3/3) (3/3) (0/3) (0/3) 
1.00E+02 (2/3) (0/3) (0/3) (0/3) (3/3) (0/3) (0/3) 
1.00E+01 (0/3) (0/3) (0/3) (0/3) (1/3) (0/3) (0/3) 
1 (0/3) (0/3) (0/3) (0/3) (0/3) (0/3) (0/3) 
≤ 10 (0/3) (0/3) (0/3) (0/3) (0/3) (0/3) (0/3) 
  
Table 2.1 Test sensitivities for various BCV detection assays by infectivity, nucleic acid-based, 
and protein-based diagnostic procedures.   
 
a BCV Conc, obtained from tissue culture derived BCV titrated by endpoint dilution and diluted 
serially to obtain test dilutions. 
b TCID50, tissue culture infecting dose 50. 
c EtBr, ethidium bromide. 
d SYBR, SYBR green. 
e Southern, Southern blot hybridization. 
f Probe, TaqMan probe. 
g 8F2 Mab, monoclonal BCV nucleoprotein (27). 
h HA, hemagglutinin activity 
i Most dilute level of virus resulting in three positive results out of three replicate samples was 
bolded. 
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CHAPTER 3 - Virucidal Activity of Biocides against Influenza A 
Viruses 
Abstract 
Influenza viruses, namely the avian H5N1 subtype, pose a great threat for pandemic 
status.  Disruption of the transmission cycle could aid in minimizing disease spread with the use 
of chemical biocides in contaminated environments.  In addition, the use of safer less pathogenic 
influenza viruses in place of the H5N1 could be conducted to safely generate efficacy data.  This 
research indicates that no significant differences existed when comparing disinfectant efficacy 
data between mammalian or avian influenza, suggesting the use of a less pathogenic influenza A 
virus in place of a more pathogenic one.  We also report that various biocides were effective in 
rapid and complete inactivation of both mammalian and avian influenza test strains and included 
DF-200d,  10% bleach, 1% Virkon® S, and 70% ethanol following 10 min exposure.  Efficacy 
of all biocides was reduced in the presence of organic challenge using 10 or 50% poultry feces.  
Treatment with DF-200d or 10% bleach resulted in significant degradation of viral RNA.  The 
virucidal procedures conducted in this study were consistent with the U.S. Environmental 
Protection Agency guidelines for virucidal efficacy claim testing.   
Introduction 
Currently, more than 30 countries have experienced outbreaks of the highly pathogenic 
avian influenza (HPAI) A virus subtype H5N1 in poultry and other avian species (63).  Due to 
the widespread status of this virus, there is a relatively high risk that an avian influenza pandemic 
outbreak could occur throughout the world.  Increased globalization and the avian influenza 
virus’ natural reservoir among migratory waterfowl (93) translate into a continuing risk for this 
disease to emergence in the U.S.  The use of chemical biocides may aid in the disruption of the 
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transmission cycle of the influenza virus and aid in containment measures to minimize disease 
spread and devastation (72, 75).    
Efficacy data specific for the H5N1 subtype is not widely available in existing literature.  
Virucidal data which does exist is often difficult to interpret or compare due to lack of 
standardized procedures for evaluating chemical biocides.  Even less information is available on 
mechanism of action of various disinfectants as well as the efficacy in the presence of organic 
challenge.  In the U.S., the Environmental Protection Agency (EPA) provides guidelines for 
efficacy testing (34, 67).  The EPA guidelines require that a disinfectant must be validated for 
each individual organism it claims to be effective against, although this is somewhat vague with 
regard to interpretation and is unclear whether this includes for example all influenza A viruses 
versus species specific or actual strains to obtain a product registration.  Due to the BSL-3 status 
of the H5N1 subtype, it is difficult to rapidly generate efficacy data during an outbreak.  The 
EPA currently maintains a list of chemical disinfectants approved for the use against avian 
influenza A viruses but there are no antimicrobial products registered specifically against the 
H5N1 subtype (3).  This document also states that the U.S. EPA believes that “based on 
available scientific information that the currently registered avian influenza A products, when 
applied in strict accordance with label directions, will be effective against the H5N1 stain.”  
Viruses belonging to the same family are believed to react similarly to chemical inactivation (47, 
75), but the use of a surrogate should be validated before making claims on the basis of surrogate 
virus efficacy testing.   
Stringent sanitation and decontamination efforts have been recommended for facilities or 
premises contaminated in the event of an avian influenza outbreak including transport vehicles, 
clothing, cages, housing, and other potential contaminated areas (22, 93).  Due to the zoonotic 
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nature of avian influenza, affected premises could range from poultry production housing and 
growing facilities to human hospital emergency rooms.  Therefore, decontamination operations 
and procedures may occur under a variety of conditions such as on relatively clean surfaces or 
surfaces that contain a very high organic matter.  A pre-cleaning wash step for the removal of 
organic material is typically recommended for decontamination to occur due to the possible 
physical protective effect of the virus particles and or the chemical neutralization of the biocide 
mechanism (23, 75).     
Influenza viruses are characterized as having an envelope and containing a segmented 
negative-stranded RNA genome, with a non-symmetrical shape approximately 80-120 nm in 
diameter belonging to the family, Orthomyxoviridae (51).  The influenza virus is composed of 
approximately 1% nucleic acid (RNA), 70% protein, 20% lipid, and 5-8% carbohydrate which 
all present as potential targets to the mechanism of inactivation of chemical biocides (51, 75, 88).  
Virus inactivation is typically accomplished by destroying the lipid envelope (if present), viral 
proteins such as the structural receptors or capsid, or the viral nucleic acid.  Enveloped viruses 
are generally not considered to be resistant to chemical inactivation due to the relatively easy 
disruption of the lipid envelope by most chemical biocides (47), but peer-reviewed efficacy data 
is not widely available in existing literature (8-11, 34).  Additionally, parameters including 
disinfectant concentration, pH, temperature, contact time, virus clumping, and the presence of 
organic material can severely impact the overall efficacy (67, 72, 75, 82, 88).  Efficacy data 
which is available is often difficult to interpret or compare due to the diversity in methodology 
for conducting such experiments by the lack in a universally accepted standard for virucidal 
testing.   
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The purpose of this study was to evaluate the efficacy of various chemical disinfectants 
against two strains of influenza A, mammalian H1N1 and low pathogenic avian influenza H5N8, 
referred to as H1N1 or H5N8, respectively.  The purpose of including both test strains in this 
research was to evaluate the validity for using closely related viruses as surrogates in place of 
more pathogenic viruses, such as the H5N1, by conducting a statistical comparison of the 
efficacy results obtained.  To evaluate the possible use of surrogate viruses for disinfectant 
efficacy in place of the more infectious HPAI, statistical analysis comparing the quantitative 
TCID50 and RNA responses post-treatment between the H1N1 and H5N8 strains was also 
included.  Biocide efficacy was determined following the EPA guidelines for evaluating 
virucidal efficacy (34).  Virus was recovered using tissue culture infective dose 50 (TCID50) in 
an appropriate host cell line.  To evaluate a possible mechanism of inactivation against the viral 
RNA, a quantitative universal real-time reverse transcriptase polymerase chain reaction (rRT-
PCR) assay was included post-treatment.  Chemical disinfectants used in this study included 
bleach, ethanol, Virkon® S (5), and DF-200d (91).  To determine the most effective disinfectants 
against the influenza A test strains, statistical analysis of the various disinfectant treatments were 
evaluated measuring the amount of infectious virus recovered post-treatment (as measured by 
TCID50 and quantitative influenza A RNA concentration) to differences in time of exposure to 
the treatment, and the presence of different organic sample matrices.   
Materials and Methods  
Virus and cells.  Mammalian influenza A/WSN/33 or low pathogenic avian influenza 
H5N8 (H5N8, provided generously by the Centers for Disease Control and Prevention, Atlanta, 
GA) was propagated in Madin-Darby Canine Kidney (MDCK, ATCC CCL-34™, Manassas, 
VA) cells to approximately 107 log10 (based on endpoint titration using TCID50).  MDCK cells 
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were maintained in Minimal Essential Medium with Earle’s salts and L-glutamine (Invitrogen 
Corporation, Carlsbad, CA) with the addition of 2.2 g/L sodium bicarbonate (Fisher Scientific, 
Hampton, NH) collectively referred to as MEM containing 10% fetal bovine serum (FBS, 
Hyclone Laboratories, Logan, UT) supplemented with 2.5 mg/L amphotericin B, 0.67 g/L 
streptomycin, and 0.3 g/L penicillin G (all from Fisher Scientific).  Infectivity media was made 
using MEM media containing antibiotics with the addition of 0.1% TPCK treated trypsin (Fisher 
Scientific).   
To determine infectious viral titers, an endpoint method tissue culture infective dose 50 
(TCID50) was completed.  The Reed-Muench method (74) was calculated in a 96-well format to 
determine the dilution of virus resulting in infection of fewer than 50% replicate wells.  Nunc 96-
well cell culture microtiter plates (Fisher Scientific) were seeded with MDCK cells and 
incubated (approximately 24 hrs, at 37oC with 5% CO2).   Once cells were monolayer, the media 
was removed and plates were washed once with 0.01 M phosphate buffered saline (PBS, pH 
7.2).  Tissue culture-derived virus (H1N1 and H5N8) was then serially diluted (ten-fold) in 
culture media to a 10-9 dilution.  The microtiter plates were inoculated by adding 25 µl of each 
virus dilution to each well.  Negative controls (culture media) were inoculated with 25 µl of 
uninfected culture media.  An additional 75 µl culture media was added to each well and the 
plate was incubated (48 hrs, 37oC with 5% CO2).  Infectivity was determined by cytopathic 
effect (CPE) as indicated by the presence of rolling or sloughing of infected cells and TCID50 
was calculated using the Reed-Muench method for estimating 50% endpoints of infectivity (74).     
Test Disinfectants. Disinfectants previously evaluated against coronavirus (18) were 
included in this study and included the following: 1 and 10 % bleach, 70% ethanol, Sandia DF-
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200 (91), and 1% Virkon® S (Antec®, Suffolk, UK) The pH values of each of the test 
disinfectants were also measured prior to use.         
Organic Matrices. Poultry feces was obtained from healthy (disease free) animals 
provided generously by the Poultry Science Unit at Kansas State University, Manhattan, KS.  
Fresh fecal samples were collected from the cage pans and weighed to 10 g and added to 100 ml 
0.01 M PBS and mixed thoroughly to prepare the poultry feces solution used for organic 
challenge. Test disinfectants were challenged with 0, 10, or 50% levels by adding 0, 1, or 5 ml 
poultry feces to 10, 9, or 5 ml test disinfectant.  
Virus Inactivation. Virus inactivation was conducted with 0%, 10%, and 50% organic 
challenge (poultry feces).  For 0% organic challenge, 10 ml of test virus (H1N1 or H5N8) at 
approximately a 107 log10 TCID50/ml concentration was added to 10 ml test disinfectant and 
exposed for 1 or 10 minutes.  For 10% organic challenge, 10 ml of test virus was added to 9 ml 
of test disinfectants containing 1 ml of 10% poultry feces and exposed for 1 or 10 minutes.  For 
50% organic challenge, 10 ml of test virus was added to 5 ml of test disinfectants containing 5 
ml of 10% poultry feces and exposed for 1 or 10 minutes.  After exposure, samples were washed 
via ultracentrifugation at 100 x G for 1 hr at 4oC.  Pellets were reconstituted with 1 ml of virus 
infectivity media.   
Post-treatment Recovery of Infectious Virus.  The titers of infectious virus were 
determined as TCID50 in cell culture using a 96-well format as previously described.  The 
disinfectant samples were serially diluted (1:10) in infectivity media and then 25 µl of each 
dilution was added in quadruplicate to the 96 well microtiter plates containing confluent MDCK 
cells.  Then, 75 µl infectivity media was added to each well and placed in an incubator for 24-48 
hours at 37oC with 5% CO2.  TCID50 was determined by evaluating cytopathic effect (CPE) 
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typical for influenza viruses as indicated by the presence of rolling or sloughing of infected cells 
and TCID50 was calculated using the Reed-Muench method (74).  
Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR). Viral 
RNA was recovered using the QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA).  
Quantitative detection of the extracted influenza RNA was conducted using rRT-PCR using a 
fluorescently labeled TaqMan probe.  The rRT-PCR primer and probe sequences were provided 
generously by the Molecular Genetics Influenza Branch, Centers for Disease Control and 
Prevention in Atlanta, GA and included a forward primer (5´- CAT GGA RTG GCT AAA GAC 
AAG ACC -3´), reverse primer (5´- AGG GCA TTT TGG ACA AAK CGT CTA -3´) and a 
fluorescently labeled probe (5´ TGC AGT CCT CGC TCA CTG GGC ACG 3´) with 6-FAM™ 
at the 5´-end and Iowa Black Fluorescent Quencher at the 3’-end (Integrated DNA Technologies, 
Coralville, IA).   
For each 25 µl reaction, 2.5 µl of the RNA sample was added to 22.5 µl of master mix 
was that contained 5 µl OneStep buffer, 1 µl dNTP, 1 µl enzyme (all from Qiagen’s OneStep 
RT-PCR kit), and 0.5 µl each of the forward and reverse primers (1 µM concentration), 2 µl 
probe (5 µM concentration), and 12.5 µl RNAse-free water.  The SmartCycler thermocycler was 
set with the following settings: Stage 1 hold (42oC, 1800 s without optics), Stage 2 hold (95oC, 
900 s without optics), Stage 3 was repeated 35 times using a 3-temperature cycle (94oC, 15 s 
without optics; 58oC, 15 s without optics, and 72oC, 30 s with optics on).  The detection 
threshold for successfully detecting influenza RNA was a FAM fluorescence signal ≥ 3 using the 
SmartCycler.     
Inhibition of rRT-PCR. To determine if the reverse transcriptase (RT) or polymerase 
chain reaction (PCR) activity were inhibited by residual or carry-over of the active chemicals 
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present in the test disinfectants in the RNA recovery process, the test disinfectants were 
evaluated.  The test disinfectants were prepared as previously described and then the samples 
were extracted using the QIAamp Viral RNA Mini Kit (Qiagen).  Following this extraction 
process (in which no RNA is present) 1.25 µl from each of the extracted test disinfectants was 
inoculated with 1.25 µl purified tissue culture derived H1N1 or H5N8 RNA (extracted using the 
same process) to obtain the total 2.5 µl volume required for the 25 µl rRT-PCR reaction.  A 
positive rRT-PCR (based on a FAM fluorescence signal ≥ 3 using the SmartCycler) result would 
indicate that no inhibition or interference was occurring.  A negative result would indicate that 
there was inhibition or interference occurring to the rRT-PCR assay.     
Post-treatment Recovery of Viral RNA. A standard curve using the rRT-PCR assay 
was developed by extracting known starting amounts of TCID50 derived H1N1 and H5N8.  
Serial 1:10 dilutions of the extracted RNA were prepared in RNAase-free water (Qiagen).  Then, 
rRT-PCR was conducted on these samples to generate cycle threshold (Ct) values.  A standard 
curve was generated based on these Ct values using the SmartCycler software.  The slope of the 
standard curve was calculated and used to quantify the amount of viral RNA recovered post-
treatment. 
Post-treated viral RNA was recovered from the test samples using the QIAamp Viral 
RNA Mini Kit.  Quantitative detection of the RNA was determined by a FAM fluorescence 
signal ≥ 3 using the SmartCycler.  Ct values obtained were converted to a quantitative measure 
of RNA based on the standard curve generated using known amounts of starting virus (reported 
as log10 RNA/TCID50 titer). 
Statistical Analysis. Statistical evaluation comparing of the level of test influenza (H1N1 
or H5N8) recovered (for infectivity by TCID50 or for RNA by quantitative rRT-PCR) following 
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the experimental treatment parameters was determined by comparing 1-way, 2-way, and 3-way 
interactions between disinfectant treatment, time (1, 10 min), and organic challenge (0%, 10%, 
50% poultry feces).  The least square of means was calculated to determine if significant 
differences were observed in any of the experiments within each test virus as well as comparing 
H1N1 to results obtained with H5N8 (for potential validation of a surrogate).  A significant 
difference resulted in a P-value < 0.05.   
Results 
Post-treatment Recovery of Infectious Virus.  The average range of untreated (positive 
control) virus recovered by TCID50 ranged from 6.68 to 7.27 (H1N1) or 6.72 to 7.55 (H5N8) 
log10 TCID50/ml (Figures 3.1-3.3).  No significant statistical differences were observed when 
comparing the amount of infectious H1N1 recovered versus the amount of infectious H5N8 
recovered for the various experimental parameters (treatment, time, organic challenge) in this 
study, P > 0.05 (Figures 3.1-3.3) suggesting that these viruses are suitable surrogates within the 
orthomyxovirus family.  Following a 1 min treatment without the addition of organic challenge, 
the most effective disinfectants were DF-200d and 10% bleach resulting in > 4.0 log10 reduction 
in titer required by EPA for virucidal efficacy claims (Figure 3.1).  Following a 10 min 
treatment, all treatments except for 1% bleach and 70% ethanol resulted in a > 4 log10 TCID50/ml 
reduction in viral titer, (Figure 3.1). The addition of 10% organic challenge significantly reduced 
the efficacy of all test disinfectants except for DF-200d or 10% bleach evaluated for both 1 and 
10 min treatments (Figure 3.2), P < 0.05.    The addition of 50% organic challenge significantly 
reduced the efficacy of all test disinfectants bleach evaluated for both 1 and 10 min treatments 
(Figure 3.3), P < 0.05.     
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Post-treatment Recovery of Viral RNA. None of the test disinfectants evaluated in this 
research demonstrated inhibition or inhibition of the rRT-PCR assay based on a positive reaction 
following the initial inhibition evaluation.  This finding is necessary to determine that any 
reduction which does occur in the amount of H1N1 or H5N8 RNA recovered post-disinfectant 
treatment is most likely explained by some mechanism of that particular disinfectant degrading 
the viral nucleic acid as opposed to inhibition or interference of the reaction.  
A standard curve was generated for both H1N1 and H5N8 RNA based on the subsequent 
Ct values obtained from the purified RNA and dilutions (extracted from pre-determined TCID50 
values of infectious virus) using the SmartCycler system.  To generate the quantitative efficacy 
data, Ct values obtained with the disinfection samples for both H1N1 and H5N8 were calculated 
by the following equation: 
y = m (x) + b; y = quantitative RNA unit/per TCID50 value, m = -0.254 (H1N1) or -0.246 
(H5N8), x = Ct value, b = 11.459 (H1N1) or 9.888 (H5N8) 
The amount of untreated (positive control) viral RNA recovered ranged  between 6.44 to 
6.88 (H1N1) or 5.75 to 5.99 (H5N8) log10 RNA/TCID50 calculated as the fluorescence intensity 
of the FAM reporter divided by the Ct value (RNA FAM/Ct).  No significant statistical 
differences were observed when comparing the amount of H1N1 RNA recovered versus the 
amount of H5N8 RNA recovered for the experimental parameters (treatment, time, organic 
challenge) in this study, P > 0.05 (Tables 3.1-3.3), regardless of organic challenge amount.  
Without the addition of organic challenge, treatment with DF-200d or 10% bleach resulted in 
significant reduction in the amount of viral RNA recovered post-treatment for 1 and 10 min 
contact times.  The degradation of viral RNA by DF-200 or 10% bleach was significantly 
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reduced for both 1 or 10 min in the presence of 10% and 50% organic challenge (Tables 3.2 and 
3.3), P < 0.05. 
Discussion 
It is not well documented how the influenza A virus is inactivated by chemical biocides.  
In order to better understand the chemical inactivation of disinfectants against the influenza 
virus, the efficacy of various test disinfectants was studied using two strains of influenza A 
(mammalian H1N1 and low pathogenic avian influenza H5N8).  The use of the two closely 
related influenza strains was included to determine how similar the inactivation results are for 
different subtypes of the same family of virus and to determine if a less pathogenic virus (such as 
LPAI H5N8) could be evaluated in place of a more infectious one (like HPAI H5N1).  No 
significant differences were observed in the efficacy data obtained for the mammalian H1N1 
isolate or the LPAI H5N8 isolate suggesting that these viruses are well suited as surrogates for 
one another.  It would be expected that the HPAI H5N1 virus would react similarly to chemical 
biocides due to its genetic relatedness to each of these test viruses and being in the same viral 
family, Orthomyxoviridae (95).  The chemical inactivation of the influenza test isolates was 
evaluated based on infectivity assays (using TCID50 titration) following the current EPA testing 
guidelines (34) to determine the efficacy compared to untreated positive control samples.  Two 
time contacts were included in this study (1 or 10 min) as well as three levels of organic 
challenge consisting of poultry feces (0, 10, or 50%).  DF-200 and 10% bleach were the most 
efficacious with a short contact time (1 min) for inactivating both influenza test strains by > 4.0 
log10 reduction in titer.  Following a longer contact time (10 min), all test disinfectants except for 
1% bleach were efficacious against both influenza test strains by > 4.0 log10 reduction in titer.  
The efficacy of all test disinfectants was reduced in the presence or organic challenge.  A 
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quantitative rRT-PCR assay was included in this study to determine if degradation of viral 
nucleic acid was occurring as a possible mechanism of action of the chemical disinfectants.  
Treatment with DF-200d or 10% bleach resulted in significant reduction with regard to the 
amount of viral RNA recovered post-treatment for 1 and 10 min contact times and were the only 
treatments found to degrade nucleic acid.  The degradation of RNA was significantly reduced in 
the presence of organic challenge.   
Due to the high level of containment required for the H5N1 virus, the less pathogenic 
mammalian H1N1 and avian H5N8 were evaluated in this study to determine their potential use 
as surrogate viruses for efficacy testing based on the similarity in efficacy.  It is expected that 
viruses among the same viral family will react similarly to chemical inactivation (47, 57, 68, 83).  
Infectious titer results obtained from the TCID50 assays in this study showed similar efficacy 
results with no significant differences when comparing both influenza test strains (H1N1 or 
H5N8) for all experimental parameters including time contact and organic challenge.  Examples 
of accepted surrogate viruses in current EPA testing guidelines include duck hepatitis B virus for 
hepatitis B virus, bovine diarrhea virus for hepatitis C virus, feline calicivirus for norovirus (34, 
83).  Bovine coronavirus or avian infectious bronchitis virus have also been suggested as safe 
surrogate viruses for disinfectant assays for the SARS virus based on the general expectation that 
viruses belonging to the same virus family react similarly to chemical disinfection (83).  These 
surrogates are generally used if the intended virus is not culturable or when high level of 
containment is necessary and less pathogenic viruses are acceptable.         
In this research, determination of infectious titer post disinfectant treatment was 
conducted based on endpoint dilution in TCID50 format.  The greatest challenge for this assay 
was the potential for chemical carry-over which would cause cytotoxicity to the MDCK cells 
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(16, 67) and ultimately prevent the recovery of any residual infectious virus.  According to 
current  EPA virucidal guidelines, disinfectants which still have some cytotoxic effect must 
“show a minimum of a 3-log reduction in titer beyond the cytotoxic level”  (34).  To overcome 
this issue, samples were washed via ultracentrifugation to pellet the virus and remove the 
chemical biocide.  DF-200d and Virkon S both remained cytotoxic at the least dilute sample in 
the TCID50 recovery process even post-ultracentrifugation, but resulted in negative CPE and 
cytotoxic effects for the 3-log10 dilution requirement included in the current EPA guidelines.  Gel 
filtration in addition to centrifugation has been shown to remove potential cytoxicity prior to 
infectivity recovery processes (79).  Other examples to overcome cytotoxicity issues in virucidal 
testing include neutralization of the chemical mechanism or dilution of the disinfectant (40), but 
reduce the detection limit of the assay depending on how much diluting is required.     
The influenza viruses used in this study were inactivated by > 4.0 log10 reduction in titer 
following a 1 min exposure.  This rapid response to chemical inactivation is consistent with the 
Klein and Deforest scheme (48) for virus susceptibility predictions indicating that enveloped 
viruses are most susceptible to chemical inactivation compared to non-enveloped viruses (67).  
This is most likely a result of the relatively easy disruption of the lipid envelope by the biocides 
used in this study, and not necessarily the disruption of other viral targets including the protein or 
nucleic acid (59, 75, 88).  Reduced efficacy in the presence of 10 and 50% levels of organic 
challenge was observed with all biocides evaluated.  The presence of organic material is known 
to disrupt  biocide mechanism and overall efficacy by a few mechanisms (57, 67, 72, 75, 88).  
Direct neutralization of the chemical activity of the biocide by the compounds of the organic 
material could disrupt efficacy.  Organic material might also disrupt the efficacy of viral 
inactivation by diluting the disinfectant and lowering the overall effect.  Another theory is that 
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the organic material provides a physical protection of the viral particles which prevents the 
interaction of the biocide and viral target.   
The recovery of the influenza test strains used in this study based on endpoint titration 
(TCID50) in MDCK cells indicate that the infectious virus was reduced by > 4 Log10 following 1 
min treatment with DF-200d and 10% bleach.  High standard deviations were apparent for 
efficacy results using 1% Virkon® S and 70% ethanol at this time exposure.  Treatment for 10 
min resulted in > 4 Log10 reduction in titer for all biocides except for 1% bleach, and could 
therefore be labeled with virucidal claims according to the current EPA guidelines (34).  The 
addition of organic challenge reduced the efficacy for all biocides evaluated in this testing.  
Treatment for 10 min with DF-220d or 10% bleach for both 10 and 50% organic challenge levels 
still maintained a > 4.0 log10 reduction in virus titer, and were the least effected by the disruption 
mechanisms in the presence of organic material (57, 68, 72, 77).  Treatment with either DF-200d 
or 10% bleach would be recommended for virucidal clean-up of a contaminated poultry facility 
based on these findings and the likelihood for organic soiling in such an environment.    
Another challenge in this research was the potential for inhibition or interference of the 
rRT-PCR assay due to chemical carry-over from the test biocides in the RNA recovery 
procedure for evaluating the possible effect of the chemical biocides on the nucleic acid.  A 
preliminary evaluation of the test biocides was conducted to verify that no inhibition was 
occurring (based on a positive rRT-PCR reaction) after inoculating the samples with purified 
viral RNA to verified that the RNA recovery procedure used in this testing successfully removed 
any inhibitory or interfering chemicals.  Treatment with DF-200d or 10% bleach were the only 
two biocides resulting in a significant effect degrading viral RNA.  The amount of H1N1 or 
H5N8 RNA recovered post-treatment did not vary significantly when comparing responses 
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obtained following short contact (1 min) or long contact (10 min), suggesting that most of the 
degradation occurs rapidly.  DF-200d and 10% bleach are characterized as strong oxidizing 
agents with hydrogen peroxide being the active ingredient in DF-200d or dissociated 
hypochlorous acid as the active ingredient in bleach (20, 33, 59).  The nucleic acid degradation 
was significantly minimized in the presence of organic challenge, likely due to neutralizing, 
diluting, or protecting mechanisms discussed previously (57, 67, 68, 72, 77).  Treatment with 1% 
Virkon S or 70% ethanol did not result in the degradation of the viral RNA.  Therefore, efficacy 
results from these treatments is most likely a result of disrupting the viral envelope or structural 
proteins necessary for successful viral replication (47, 52, 55, 57, 59, 88, 95). 
The recovery of influenza RNA based on rRT-PCR resulted in significant nucleic acid 
degradation occurring following treatment with 10% bleach and 100% DF-200d.  The 
degradation of viral RNA is most likely a result of the strong oxidizing mechanism from the 
dissociation of hypochlorous acid from the 10% bleach solution (33) or the hydrogen peroxide 
and peracetate acid formation occurring in the chemistry of the 100% DF-200d (20).  The other 
test disinfectants evaluated in this research (25 and 50% DF-200d, 1% bleach, 1% Virkon S, 
70% ethanol) did not demonstrate any degradation occurring when compared to the non-treated 
positive control samples.  It is likely that any loss of infectivity occurring from these treatments 
was a result of action against the viral envelope or structural proteins (47, 52, 55, 57, 68, 95).   
Separate disinfectant studies with influenza viruses have been conducted but are difficult 
to compare due to differences in the test methodologies used for determining the virucidal 
efficacy.  In one report, an LPAI H7N2 virus was found to be completely inactivated by 
exposure to 70% ethanol for approximately 30 min (54).  This study also showed that H7N2 was 
sensitive to an acidic pH value (of 2) and relatively high temperature (56oC) after approximately 
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30 min exposure.  Shorter contact times were not evaluated, so inactivation could have occurred 
faster than what was actually evaluated.  In another report, virucidal evaluation was conducted 
using a formaldehyde-containing disinfectant and an organic acid-based disinfectant against an 
LPAI H7N1 isolate following the guidelines of the German Veterinary Association to address 
efficacy at reduced temperatures and in the presence of organic  material using fetal calf serum 
(96).  This study found that both disinfectants were efficacious if applied at 20oC, but efficacy 
was significantly reduced at 10 or 4oC and in the presence of organic material.  Disinfectant 
efficacy has also been reported against a nonpathogenic H7N2 avian isolate with the addition of 
antifreezing compounds to four biocides (phenol, quaternary ammonium, quaternary ammonium 
combined with formaldehyde, and sodium hypochlorite) to address efficacy at reduced 
temperatures (29).  The study was conducted following a modification of the use-dilution 
analysis of the Association of Official Agricultural Chemists for bacteria and found that the 
antifreezing compounds reduced the efficacy for the quaternary ammonium combined with 
formaldehyde and the sodium hypochlorite disinfectants but not the phenol or quaternary 
ammonium compounds.      
Influenza viruses have also been shown to persist on various surfaces, which could aid in 
disease spread if not properly decontaminated.  In an environmental study conducted using 
influenza A and B viruses, infectious virus could be recovered from non-porous surfaces (such as 
metal or plastic) for up to 48 h and from materials such as cloth, paper, or tissue for up to 12 h 
with 35-40% humidity at 28oC (14).  In addition to surface decontamination, influenza virus has 
also been shown to spread via aerosols, large droplets, or contact with infectious secretions or 
fomites (87), further emphasizing the need for stringent sanitation and disinfection regimens to 
be in place to aid in containment efforts (94).     
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Due to the potential effect that chemical biocides might have on viral nucleic acid, one 
study was conducted to evaluate this effect on avian influenza H7N2 detected by real time RT-
PCR (86).  In this study phenol, quaternary ammonium, Virkon S, and sodium hypochlorite were 
evaluated using a 10 min or 1 hr contact time to determine if degradation of viral RNA was 
occurring.  Results reported for the 1 hr contact time indicate that all disinfectants were found to 
be effective at inactivating the virus by an infectivity assay, but only treatment with Virkon S 
and sodium hypochlorite were found to degrade the RNA.  The data on degrading nucleic acid 
was not reported for the 10 min exposure.  In our study, the viral RNA was degraded 
significantly by 10% sodium hypochlorite, but not significantly by Virkon S.  Based on these 
results, it’s likely that degradation of the nucleic acid does occur with Virkon S but requires the 
longer contact time.            
In conclusion, we report that various disinfectant chemistries were effective in rapid and 
complete inactivation of both mammalian influenza H1N1 and LPAI H5N8 including 10% 
bleach, 50 and 100% DF-200d, and 1% Virkon® S following a 10 min exposure based on the 
current EPA guidelines for evaluating the efficacy of chemical disinfectants for virucidal activity 
(34).  There were no significant differences in the efficacy results obtained between the two test 
strains indicating efficacy of all test disinfectants evaluated was reduced in the presence of 
organic challenge due to both a neutralizing effect of the chemical mechanism as well as a 
physical protective effect of the matrix for the virus particles.   
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Figure 3.1 Infectivity of H1N1 and H5N8 as measured by TCID50/ml following 1 and 10 min 
exposure to chemical biocides with no organic challenge.    
 
CONT, Control (0.01 M PBS in place of disinfectant); DF-200d, Decontamination Formulation; 
10% NaOCl, 10% sodium hypochlorite; 1% NaOCl, 1% sodium hypochlorite; VIRKON, 1% 
Virkon S; 70% EtOH, 70% ethanol 
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Figure 3.2 Infectivity of H1N1 and H5N8 as measured by TCID50/ml following 1 and 10 min 
exposure to chemical biocides in the presence of 10% feces.    
 
CONT, Control (0.01 M PBS in place of disinfectant); DF-200d, Decontamination Formulation; 
10% NaOCl, 10% sodium hypochlorite; 1% NaOCl, 1% sodium hypochlorite; VIRKON, 1% 
Virkon S; 70% EtOH, 70% ethanol 
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Figure 3.3 Infectivity of H1N1 and H5N8 as measured by TCID50/ml following 1 and 10 min 
exposure to chemical biocides in the presence of 50% feces.    
 
CONT, Control (0.01 M PBS in place of disinfectant); DF-200d, Decontamination Formulation; 
10% NaOCl, 10% sodium hypochlorite; 1% NaOCl, 1% sodium hypochlorite; VIRKON, 1% 
Virkon S; 70% EtOH, 70% ethanol 
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 Treatment                         1 min                         10 min   
  H1N1 H5N8 H1N1 H5N8 
Conta 6.88 5.86 6.70 5.89 
DF200db 1.33 2.05 0.00 0.62 
10% NaOClc 0.86 0.00 0.00 0.96 
1% NaOCld 5.85 5.37 6.68 5.86 
VIRKONe 5.92 5.47 4.54 5.25 
70% EtOHf 5.69 5.88 6.91 5.74 
  
Table 3.1 Quantitative rRT-PCR reported as log10 RNA/TCID50 units following 1 or 10 minute 
exposure to test disinfectants in the presence of no organic challenge.    
 
a Cont, Control (0.01 M PBS in place of disinfectant) 
b DF-200d, Decontamination Formulation 
c 10% NaOCl, 10% sodium hypochlorite 
d 1% NaOCl, 1% sodium hypochlorite 
e VIRKON, 1% Virkon S 
f 70% EtOH, 70% ethanol 
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 Treatment                         1 min                         10 min   
  H1N1 H5N8 H1N1 H5N8 
Conta 6.78 5.99 6.55 5.91 
DF200db 3.05 3.44 1.09 1.54 
10% NaOClc 0.00 0.00 0.00 0.85 
1% NaOCld 6.65 5.84 6.41 6.06 
VIRKONe 6.57 5.30 6.42 4.91 
70% EtOHf 6.66 5.83 6.49 5.39 
  
Table 3.2 Quantitative rRT-PCR reported as log10 RNA/TCID50 units following 1 or 10 minute 
exposure to test disinfectants in the presence of 10% organic challenge.    
 
a Cont, Control (0.01 M PBS in place of disinfectant) 
b DF-200d, Decontamination Formulation 
c 10% NaOCl, 10% sodium hypochlorite 
d 1% NaOCl, 1% sodium hypochlorite 
e VIRKON, 1% Virkon S 
f 70% EtOH, 70% ethanol 
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 Treatment                         1 min                         10 min   
  H1N1 H5N8 H1N1 H5N8 
Conta 6.44 5.75 6.47 5.88 
DF200db 5.82 4.77 5.80 4.87 
10% NaOClc 6.01 5.51 6.26 5.23 
1% NaOCld 5.84 5.66 5.94 5.81 
VIRKONe 6.19 5.49 6.37 5.40 
70% EtOHf 6.47 5.42 6.94 5.79 
  
Table 3.3 Quantitative rRT-PCR reported as log10 RNA/TCID50 units following 1 or 10 minute 
exposure to test disinfectants in the presence of 50% organic challenge.    
 
a Cont, Control (0.01 M PBS in place of disinfectant) 
b DF-200d, Decontamination Formulation 
c 10% NaOCl, 10% sodium hypochlorite 
d 1% NaOCl, 1% sodium hypochlorite 
e VIRKON, 1% Virkon S 
f 70% EtOH, 70% ethanol 
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CHAPTER 4 - Inactivation of Foot and Mouth Disease Virus and 
Bovine Enterovirus 
Abstract 
Foot and Mouth Disease virus (FMDV) is recognized as one of the most economically 
important diseases of food animals.  This virus is highly contagious and can persist in the 
environment for extended periods, making containment and eradication efforts difficult.  
Chemical decontamination of affected premises could aid in disease containment and facility 
restoration.  The purpose of this study was to evaluate the chemical inactivation of FMDV and a 
closely related virus, bovine enterovirus (BEV), to determine if surrogate efficacy testing is valid 
for FMDV.  In this study, 10 min treatment with 5% acetic acid, 10% bleach, 4% sodium 
carbonate, 2% sodium hydroxide, and Sandia DF-200 were effective at inactivating FMDV.  
Treatment with 5% acetic acid was not effective for inactivating BEV.  Treatment with 70% 
ethanol was not effective for inactivating FMDV or BEV.  Additionally, 10 min treatment with 
10% bleach, 2% sodium hydroxide, and Sandia DF-200 were shown to degrade the nucleic acid 
(RNA) of both test viruses. 
Introduction 
Foot and Mouth disease virus (FMDV) is a highly infectious disease occurring in cloven-
hoofed animals and is known to spread by direct contact from infected animals, contaminated 
animal products such as feces, urine, milk, semen, by the airborne route, and by mechanical 
means from contaminated surfaces, people, and by vehicles (1, 78).  Consequently, FMDV is 
considered one of the most infectious diseases known to exist (41) and rapid containment and 
eradication efforts are necessary to minimize animal suffering and economic loss.  
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Decontamination of the infected premises during an outbreak is recommended during 
containment and eradication efforts before naïve animals can be reintroduced.  
Existing literature in the area of disinfectant efficacy specific for FMDV is of limited 
value by virtue of the diverse testing methodologies used.  Furthermore, much of the published 
data was produced in the late 1950’s to late 1970’s (12, 26, 35-37, 66, 81), and precedes current 
standardization and guidelines issued by various agencies for virucidal testing (8-11, 15, 24, 30, 
34).  Additionally, strong evidence exists to support the survival and persistence of FMDV in the 
environment if inadequate decontamination measures are in place (26, 37, 38, 42, 66, 71, 80, 89), 
further supporting the need to have virucidal data available for FMDV.  The U. S. Environmental 
Protection Agency (EPA) has published guidelines for evaluating disinfectants for virucidal 
claims and also recommends that testing be conducted against a specific viral target (34).  In 
some cases, disinfectant efficacy testing with surrogate viruses is allowed in the case of non-
culturable pathogens including duck hepatitis B virus for hepatitis B virus, bovine diarrhea virus 
for hepatitis C virus, and feline calicivirus for norovirus (34, 83).  Due to the difficulty in 
working with FMDV in the U. S. (which can only be conducted at the Plum Island Foreign 
Animal Disease Center in Greenport, NY), the potential use of a surrogate virus for disinfectant 
efficacy testing is highly desired.   
Strong evidence exists to support the survival and persistence of FMDV in the 
environment making containment and eradication difficult (26, 37, 38, 42, 66, 71, 80, 89).  
Although culling, slaughter, and vaccination programs are often used as the major eradication 
efforts for FMDV outbreaks, affected premises cannot be released to susceptible populations of 
animals until adequate decontamination and restoration efforts are completed and verified due to 
the persistence of this virus.  FMDV belongs to the Picornaviridae family, and as a non-
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enveloped virus is more resistant than enveloped viruses to chemical inactivation according to 
the Klein and Deforest virus susceptibility prediction scheme (47).  Because FMDV does not 
have a lipid envelope, chemical biocides must degrade or denature the capsid proteins and or the 
nucleic acid material to effectively inactivate the virus (75).  In addition to the resistance of this 
virus, the presence of organic material such as feces, urine, blood, or soil in the affected premises 
can also disrupt the mechanism of the chemical biocide by diluting, neutralizing, or preventing 
contact to the target (72).        
Viruses are divided into several subgroups with regard to their resistance to disinfectants.  
Differences observed are based largely on the presence or absence of a viral envelope and the 
size of the virus particle.  According to the Klein and Deforest (47) schematic for dividing viral 
groups, the least resistant to disinfectants are the enveloped viruses (ie. influenza, coronavirus);  
those with moderate resistance are the large non-enveloped viruses (ie. adenovirus); and those 
with the most resistance are the small non-enveloped viruses (ie. picornavirus, parvovirus) 
including FMDV.  These subgroups of viruses are often termed category A, C, and B, 
respectively.  Category A and C are the least resistant, and disinfectants such as hypochlorite, 
alkalis, oxidizing agents, and aldehydes are all very effective (7).  Category B viruses, including 
FMDV, are the most resistant viruses and great care must be taken to ensure complete 
inactivation.  
The purpose of this study was to evaluate the efficacy of various chemical disinfectants 
against bovine enterovirus (BEV) under BSL2 conditions and against FMDV under BSL3 
conditions to consider the use of BEV as a possible surrogate virus against FMDV for generating 
virucidal efficacy data.  Suspension tests were used to evaluate several chemical biocides 
following published EPA virucidal testing methods.  Statistical analysis was conducted 
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comparing the quantitative tissue culture infective dose TCID50 and quantitative RNA responses 
resulting for BEV and FMDV following treatment with the test disinfectants.  Virus was 
recovered using the TCID50 method in an appropriate host cell line.  A quantitative real-time 
reverse transcriptase polymerase chain reaction (rRT-PCR) assay specific for BEV or FMDV 
was also evaluated to determine if disinfectant chemistry resulted in significant degradation of 
viral RNA.  In both recovery systems, statistical analysis was conducted to determine if the 
disinfectant treatment resulted in significant reduction in viral titer when compared to non-
treated positive control samples.  Chemical disinfectants used in this study included acetic acid, 
bleach, ethanol, sodium carbonate, sodium hydroxide, and novel chemistries including Sandia 
DF-200 (91), Oxy-Sept® 333 (2), and Virkon® S (5).  Sandia DF-200 is a unique blend of 
quaternary ammonium compounds and peroxide for synergistic mechanism of action.  Oxy-
Sept® 333 is an oxidizer with surfactant ingredients to aid in surface penetration and to resist 
breakdown in the presence of organic compounds.  Virkon® S is an oxidizer with surfactant 
ingredients to aid in surface penetration, but initial cleaning is recommended to remove heavy 
organic material.  Disinfectants were exposed for 10 or 20 min and challenged in the presence of 
0, 10, or 50% bovine feces to represent organic soiling of an infected premise.   
Materials and Methods 
Virus and cells.  BEV-2 (ATCC VR-754, Manassas, VA) was propagated in Madin 
Darby Bovine Kidney (MDBK, ATCC CCL-22) cells.  FMDV type O1 strain Brugge was 
propagated in Baby Hamster Kidney 21 (BHK-21, ATCC CCL-10) cells.   MDBK and BHK-21 
cells were propagated in minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's 
BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 
mM sodium pyruvate with 10% fetal bovine serum (FBS, Hyclone Laboratories, Logan, UT) 
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supplemented with 2.5 mg/L amphotericin B, 0.67 g/L streptomycin, and 0.3 g/L penicillin.  
MDBK cells were infected with BEV-2 without the addition of 10% FBS.  BHK-21 cells were 
infected with FMDV using 4% FBS.  Inoculum titer was assessed using tissue culture infective 
dose 50, TCID50 and calculated by the Reed-Muench method (74).   
Test Disinfectants. A 5% solution of acetic acid (Fisher Scientific, Hampton, NH) was 
prepared by adding 5 ml acetic acid to 95 ml sterile deionized water.  A 10% solution of bleach 
was prepared by adding 10 ml concentrated Clorox® (6.15% sodium hypochlorite, Oakland, 
CA) to 90 ml sterile deionized water.  A 70% solution of ethanol (100% anhydrous ethanol, 
Fisher Scientific) was prepared by adding 70 ml 100% ethanol to 30 ml sterile deionized water.  
A 4% solution of sodium carbonate (Fisher Scientific) was prepared by adding 4 g sodium 
carbonate to 100 ml sterile deionized water.  A 2% solution of sodium hydroxide (Fisher 
Scientific) was prepared by adding 2 g sodium hydroxide to 100 ml sterile deionized water.  
Decon Foam (Sandia DF-200, Albuquerque, NM) (91), was supplied by Sandia National 
Laboratories and was prepared by mixing 2.45 ml of Part 1 (surfactants and fatty acids) to 0.1 ml 
Part 3 (a diacetin-based propellant) and then 2.45 ml of Part 2 (hydrogen peroxide, 7.99%) was 
added and mixture was thoroughly mixed to yield the 100% test concentration of DF-200.  Oxy-
Sept® 333 was purchased from Ecolab® (St. Paul, MN) and a 0.4% recommended solution was 
prepared by adding 400 µl Oxy-Sept® 333 to 100 ml sterile deionized water.  Virkon® S was 
purchased from DuPont Animal Health Solutions (Antec®, Suffolk, UK) and a 1% solution 
recommended by the manufacturer was prepared by adding 0.1 g to 10 ml sterile deionized 
water.  Test disinfectants were prepared fresh each time prior to use.  The pH values of each of 
the test disinfectants were also measured and recorded prior to use.         
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Organic Matrices. Bovine feces was collected from healthy (disease free) animals.  A 
10-g portion of fresh fecal sample was to 100 ml 0.01 M PBS, mixed thoroughly and centrifuged 
(400 RCF, 10 min) to clarify the fecal solution to be used for organic challenge.  Test 
disinfectants were challenged with 0, 10, or 50% levels by adding 0, 1, or 5 ml bovine fecal 
solution to 10, 9, or 5 ml test disinfectant.  
Virus Inactivation. Virus inactivation was conducted with 0%, 10%, and 50% organic 
challenge (bovine feces) using current EPA virucidal testing guidelines (34).  For 0% organic 
challenge, 10 ml of test virus (BEV-2 or FMDV) at approximately a 106 log10 TCID50/ml 
concentration was added to 10 ml test disinfectant and exposed for 10 or 20 min.  For 10% 
organic challenge, 10 ml of test virus was added to 9 ml of test disinfectants containing 1 ml 
bovine feces and exposed for 10 or 20 min.  For 50% organic challenge, 10 ml of test virus was 
added to 5 ml of test disinfectants containing 5 ml bovine feces and exposed for 10 or 20 
minutes.  Following exposure, disinfectant samples were washed via ultracentrifugation at 100 x 
G for 1 hr at 4oC.  Pellets were reconstituted with 1 ml infectivity media.   
Post-treatment Recovery of Infectious Virus.  The titers of infectious virus were 
determined as TCID50 in cell culture using a 96-well format.  The disinfectant samples were 
serially diluted (1:10) in infectivity media and then 25 µl of each dilution was added in 
quadruplicate to the 96 well microtiter plates containing confluent MDBK or BHK-21 cells for 
BEV-2 or FMDV, respectively.  Then, 75 µl infectivity media was added to each well and plates 
were placed in an incubator for 24-48 hours at 37oC with 5% CO2.  TCID50 was determined 
visually by evaluating cytopathic effect (CPE) typical for BEV-2 and FMDV as indicated by the 
presence of rolling or sloughing of infected cells and TCID50 was calculated using the Reed-
Muench method (74).  
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Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR). BEV-2 or 
FMDV RNA was recovered using the RNeasy Kit (Qiagen, Valencia, CA).  Quantitative 
detection of the extracted RNA was conducted using rRT-PCR using a fluorescently labeled 
TaqMan probe.  The rRT-PCR and probe sequences for BEV-2 were obtained from Onodera and 
Melcher, 2002 (64) and for FMDV obtained from Callahan et al., (2002) (21).  
For BEV-2 rRT-PCR, the OneStep RT-PCR kit (Qiagen) was used.  For FMDV rRT-
PCR, the GeneAmp® Ez rTth RNA PCR kit (Applied Biosystems, Foster City, CA).  For each 
25 µl reaction, 2.5 µl of the RNA sample was added to 22.5 µl of master mix prepared following 
the manufacturers’ recommendation for the OneStep RT-PCR kit or the GeneAmp® Ez rTth 
RNA PCR kit.  The SmartCycler® thermocycler conditions are shown in Table 2 for BEV-2 and 
FMDV.   
Inhibition of rRT-PCR. To determine if inhibition or interference was occurring in the 
rRT-PCR assays for either BEV-2 or FMDV, the test disinfectants were prepared as control 
solutions as previously described and then were extracted using the RNeasy Mini Kit.  Following 
this extraction process (in which no RNA is present) 1.25 µl from each of the extracted test 
disinfectants was inoculated with 1.25 µl purified tissue culture derived BEV-2 or FMDV RNA 
(extracted using the same process) to obtain the total 2.5 µl volume required for the 25 µl rRT-
PCR reaction.  The rRT-PCR assay was conducted for each sample and a positive rRT-PCR 
based on a FAM fluorescence signal ≥ 3 would indicate that no inhibition or interference was 
occurring (18).  A negative result would indicate that there was inhibition or interference 
occurring to the rRT-PCR assay.     
Post-treatment Recovery of Viral RNA. In order to have a quantitative rRT-PCR for 
BEV-2 or FMDV, a standard curve was generated using the SmartCycler®.  BEV-2 or FMDV 
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were titrated using TCID50 and RNA was purified using the RNeasy Mini Kit as previously 
described.  Serial 1:10 dilutions of the extracted RNA were prepared in RNAase-free water 
(Qiagen).  Then, rRT-PCR was conducted on both viral samples to generate subsequent Ct 
values for each dilution.  A standard curve was generated based on these Ct values using the 
SmartCycler® software by incorporating the TCID50 derived titers for the resulting Ct value.  
The slope of the standard curve was calculated and used to quantify the amount of viral RNA 
recovered post-treatment. 
Post-treated viral RNA was recovered from the test samples using the RNeasy Mini Kit.  
Quantitative detection of the RNA was determined by a FAM fluorescence signal ≥ 3 using the 
SmartCycler® using rRT-PCR assays for BEV-2 or FMDV.  Ct values obtained were converted 
to a quantitative measure of RNA based on the standard curve generated using known amounts 
of starting virus (reported as log10 RNA/TCID50 titer). 
Statistical Analysis. An analysis to assess the statistical differences in the level of virus 
(BEV-2 or FMDV) recovered by TCID50 or by quantitative rRT-PCR following the experimental 
treatment parameters was carried out by comparing 1-way, 2-way, and 3-way interactions 
between disinfectant treatment, time (10, 20 min), and organic challenge (0%, 10%, 50% feces).  
The least square of means was calculated to determine if significant differences were observed 
comparing BEV-2 efficacy results to FMDV efficacy results.  A significant difference between 
treatments is inferred with a P-value ≤ 0.05.   
RESULTS 
Post-treatment Recovery of Infectious Virus.  The average infectious titer (non-treated, 
positive control) was 6.04 or 6.50 log10 TCID50/ml for BEV-2 or FMDV, respectively (Tables 
4.2- 4.3).  The pH values of each test disinfectant are shown in Table 4.1.  Acidic disinfectants 
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included 5% acetic acid, 0.4% Oxy-Sept® 333, and 1% Virkon® S.  Basic disinfectants included 
10% bleach, 4% sodium carbonate, 2% sodium hydroxide, and Sandia DF-200.  70% Ethanol 
was considered neutral.  Effective treatments were inferred by observations of a statistically 
significant reduction (P ≤ 0.05) in infectious titer of each test virus when compared to the non-
treated positive control sample.  In addition to statistical significance, the total reduction in 
infectious titer must be ≥ 4.0 log10 TCID50/ml to meet the current requirement for virucidal 
efficacy in the U. S. EPA guidelines (34).  If no infectious virus could be recovered in the 
TCID50 assay based on the absence of CPE, then the detection limit (1.80 log10 TCID50/ml) was 
reported.   
Following 10 min exposure with the experimental disinfectants, effective treatments 
(statistically significant and resulting in a > 4.0 log10 reduction in titer) for both viruses included 
10% bleach, 2% sodium hydroxide, Sandia DF-200, 0.4% Oxy-Sept® 333, and 1% Virkon® S 
(Table 4.2).  Ten-min treatments with 5% acetic acid or 4% sodium carbonate were effective 
against FMDV, but not BEV-2 (Table 4.2).  Treatment with 70% ethanol did not result in a 
significant reduction in titer for BEV-2 or FMDV, P > 0.05.  There was no significant effect of 
the presence of organic material (10 or 50% bovine feces) disrupting the mechanism of action of 
the experimental disinfectants in this study (P > 0.05) as shown in Table 4.2. 
Following 20 min exposure with the experimental disinfectants, effective treatments 
(statistically significant and resulting in a > 4.0 log10 reduction in titer) for both viruses included 
10% bleach, 4% sodium carbonate, 2% sodium hydroxide, Sandia DF-200, 0.4% Oxy-Sept® 
333, and 1% Virkon® S (Table 4.3). Twenty-min treatment with 5% acetic acid was effective 
against FMDV, but not BEV-2 (Table 4.3).  Twenty min treatment with 70% ethanol did not 
result in a significant reduction in titer for BEV-2 or FMDV (P > 0.05).  As with the 10 min 
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recovery results, there was no significant effect of the presence of organic material (10 or 50% 
bovine feces) disrupting the mechanism of action of the experimental disinfectants in this study 
(P > 0.05) as shown in Table 4.3. 
Post-treatment Recovery of Viral RNA. The average amount of non-treated positive 
control viral RNA recovered was 5.65 or 7.04 log10 as measured from predetermined TCID50/ml 
titers for BEV-2 or FMDV, respectively (Tables 4.4, 4.5).  Effective disinfectant treatments are 
indicated by a statistically significant reduction (P ≤ 0.05) in the amount of RNA detected for 
both viruses when compared to the amount of RNA recovered from the non-treated positive 
control samples.  Only results obtained with 0 and 10% bovine feces are reported in Tables 4.4 
and 4.5 as the organic challenge with 50% bovine feces was found to be inhibitory of the overall 
rRT-PCR assay.     
     Following 10 min exposure with the experimental disinfectants, effective treatments 
for both viruses included 10% bleach, 2% sodium hydroxide, and Sandia DF-200 (Table 4.4).  
Ten min treatment with 4% sodium carbonate was effective against FMDV RNA, but not BEV-2 
RNA (Table 4.4).  Treatments with 5% acetic acid, 70% ethanol, 0.4% Oxy-Sept® 333, or 1% 
Virkon® S did not result in a significant reduction of BEV-2 or FMDV RNA (P > 0.05).  With 
most disinfectants, there was a significant effect in the presence of 10% organic material against 
the mechanism for degrading viral RNA (P ≤ 0.05) as shown in Table 4.4.   
Following 20 min exposure with the experimental disinfectants, effective treatments for 
both viruses included 10% bleach, 2% sodium hydroxide, and Sandia DF-200 (Table 4.5).  
Twenty min treatment with 4% sodium carbonate or Oxy-Sept® 333 was effective against 
FMDV RNA, but not BEV-2 RNA (Table 4.5).  Treatments with 5% acetic acid, 70% ethanol, or 
1% Virkon® S did not result in a significant reduction of BEV-2 or FMDV RNA (P > 0.05).  A 
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significant effect in the presence of 10% organic material against the mechanism for degrading 
viral RNA was observed for most disinfectants evaluated (P ≤ 0.05) as shown in Table 4.5.   
Discussion 
Available data on virucidal efficacy of chemical biocides against FMDV suffers from 
diverse or non-standardized methodology used for generating such data and is somewhat 
outdated, with much of this work being conducted during the late 1950s through the 1970s (35, 
36, 66, 81).  To better understand the virucidal efficacy of chemical biocides against FMDV, the 
efficacy of various disinfectants against FMDV type O1 strain Brugge was evaluated.  To 
evaluate the use of a possible surrogate virus for generating efficacy data under BSL-2 
conditions, bovine enterovirus (BEV) was also evaluated as a member of the Picornaviridae 
virus family.  Biocide efficacy was determined using the EPA guidelines requiring a total 
reduction in infectious titer ≥ 4.0 log10 TCID50/ml (18, 34).  Infectious virus was recovered and 
quantified byTCID50.  Treatment with 10% bleach, 2% sodium hydroxide, Sandia DF-200, 0.4% 
Oxy-Sept® 333, and 1% Virkon® S exposed for 10 min resulted in the inactivation of both 
viruses.  Treatment with 5% acetic acid or 4% sodium carbonate was effective against FMDV, 
but not BEV-2.  Treatment with 70% ethanol was not effective against BEV-2 or FMDV.  
Treatment with 10% bleach, 4% sodium carbonate, 2% sodium hydroxide, Sandia DF-200, 0.4% 
Oxy-Sept® 333, and 1% Virkon® S exposed for 20 min resulted in the inactivation of both 
viruses.  A quantitative rRT-PCR assay specific for BEV or FMDV was also evaluated to 
evaluate the effect on viral RNA post-treatment with the chemical biocides.  BEV-2 and FMDV 
RNA was significantly reduced following 10 min exposure to 10% bleach, 2% sodium 
hydroxide, and Sandia DF-200, with 4% sodium carbonate being efficacious against FMDV 
RNA, but not BEV-2 RNA.  Effective treatments following a 20 min exposure were the same as 
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for the 10 min, except treatment with 0.4% Oxy-Sept® 333 was also effective against FMDV 
RNA, but not BEV-2 RNA.   
It is generally accepted that viruses closely related or sharing characteristic features such 
as being enveloped or non-enveloped will react similarly to chemical inactivation, and is the 
basis for the Klein and Deforest prediction schemes for virus susceptibility to disinfectants (47, 
68).  In this study, BEV-2 was evaluated as a possible surrogate for FMDV in an effort to 
generate efficacy data under less stringent BSL-2 conditions.  In addition, FMDV can only be 
handled at the Plum Island Foreign Animal Disease Center in Greenport, NY, making it even 
more difficult to generate disinfectant efficacy results.  Our results showed that FMDV was 
consistently inactivated by 5% acetic acid at both 10 and 20 min exposure, but that BEV-2 was 
not.  This is most likely explained due to the enteric nature of BEV-2, which must be able to 
survive in the acidic conditions of the gastric environment during the course of its infectious life 
cycle (65).  FMDV is characterized as being unstable at a pH less than 6.5 (72), so inactivation 
by acidic compounds is not surprising.  BEV-2 was shown to be inactivated by two of the acidic 
disinfectants including 0.4% Oxy-Sept® 333 and 1% Virkon® S, even though it was resistant to 
5% acetic acid.  This is most likely a result of the novel chemistries of these two disinfectants 
including a surfactant which likely aided in the oxidative efficacy regardless of pH.  An 
important consideration for acidic or basic disinfectants is the stability of the pH in the presence 
of organic material.  As long as the active pH is maintained, the mechanism for inactivation 
against pH-sensitive viruses such as FMDV should still occur (66, 81).  
In this study, the presence of organic material at 10 or 50% bovine feces did not appear to 
disrupt the mechanism of action of the test disinfectants evaluated.  This is not consistent with 
previous observations evaluating the inactivation of bovine coronavirus (18), or with information 
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widely available in the literature regarding virus inactivation (15, 42, 47, 57, 68, 71, 75).  The 
presence of organic material has been described as breaking down the chemical mechanism for 
inactivation by dilution, neutralization, and physical protection of the virus particles (71).  It is 
not fully clear why the organic material levels evaluated in this study did not appear to have any 
significant fact on the observed efficacy.  It is possible that if a reduced contact time (less than 
10 min) which would most likely not result in complete virus inactivation by most disinfectants 
was evaluated, that some effect of the organic material might be more apparent or significant.   
Degradation of viral RNA as a mechanism of inactivation was shown to occur with 10 
min treatment with 10% bleach, 2% sodium hydroxide, and Sandia DF-200 for both viruses.  
Following a 20 min treatment, 4% sodium carbonate and 0.4% Oxy-Sept® 333 appeared to 
degrade FMDV RNA, but not BEV-2 RNA.  The use of the quantitative rRT-PCR assays for the 
recovery of BEV-2 and FMDV RNA were similar to infectious titer recovery by TCID50 assay 
for 10% bleach, 2% sodium hydroxide, or Sandia DF-200.  Although 4% sodium carbonate, 
0.4% Oxy-Sept® 333, and 1% Virkon® S all resulted in significant reductions of infectious titer, 
there was not a significant reduction in the amount of viral RNA present.  This finding suggests 
that these disinfectants are efficacious through the denaturing or breakdown of the capsid protein 
which would prevent the infectious life cycle.  The use of rRT-PCR as a measure of the efficacy 
of a decontamination effort could only be applied following treatment with 10% bleach, 2% 
sodium hydroxide, or Sandia DF-200.    
In conclusion, several disinfectants were found to be effective for inactivating FMDV 
following the current EPA guidelines for virucidal efficacy claims and included 5% acetic acid, 
10% bleach, 4% sodium carbonate, 2% sodium hydroxide, Sandia DF-200, 0.4% Oxy-Sept® 
333, and 1% Virkon® S if exposed for 10 min.  BEV-2, a closely related member in the same 
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viral family as FMDV, showed elevated resistance to the acid 5% acetic acid.  Due to the 
differences in pH stability, BEV-2 or any other enteric virus would most likely not be a suitable 
surrogate for a pH-sensitive agent such as FMDV.  Other non-enteric viruses among the 
Picornaviridae virus family should be considered for possible use as an appropriate surrogate.    
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Figure 4.1 The percentage survival rate for BEV-2 and FMDV as recovered by TCID50 
following 10 min exposure to test disinfectants in the presence of no organic challenge.   
 
Error bars indicate 1 standard deviation (n = 3).   AA, 5% acetic acid; BLCH, 10% bleach; 
ETOH, 70% ethanol; NA2CO3, 4% sodium carbonate; NAOH, 2% sodium hydroxide; DF-200, 
Sandia Decon Foam; OXYSEPT, 0.4% Oxy-Sept® 333; VIRKON, 1% Virkon® S. 
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Figure 4.2 The percentage survival rate for BEV-2 and FMDV as recovered by TCID50 
following 20 min exposure to test disinfectants in the presence of no organic challenge.   
 
Error bars indicate 1 standard deviation (n = 3).   AA, 5% acetic acid; BLCH, 10% bleach; 
ETOH, 70% ethanol; NA2CO3, 4% sodium carbonate; NAOH, 2% sodium hydroxide; DF-200, 
Sandia Decon Foam; OXYSEPT, 0.4% Oxy-Sept® 333; VIRKON, 1% Virkon® S. 
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Figure 4.3 The percentage virus recovered by TCID50 or quantitative rRT-PCR for BEV-2 and 
FMDV following 10 min exposure to test disinfectants in the presence of no organic challenge.   
 
AA, 5% acetic acid; BLCH, 10% bleach; ETOH, 70% ethanol; NA2CO3, 4% sodium carbonate; 
NAOH, 2% sodium hydroxide; DF-200, Sandia Decon Foam; OXYSEPT, 0.4% Oxy-Sept® 333; 
VIRKON, 1% Virkon® S. 
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Figure 4.4 The percentage virus recovered by TCID50 or quantitative rRT-PCR for BEV-2 and 
FMDV following 20 min exposure to test disinfectants in the presence of no organic challenge.   
 
AA, 5% acetic acid; BLCH, 10% bleach; ETOH, 70% ethanol; NA2CO3, 4% sodium carbonate; 
NAOH, 2% sodium hydroxide; DF-200, Sandia Decon Foam; OXYSEPT, 0.4% Oxy-Sept® 333; 
VIRKON, 1% Virkon® S. 
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Disinfectant pH Value 
5% acetic acid 2.3 
10% bleach 11.54 
70% ethanol 6.68 
4% sodium carbonate 11.71 
2% sodium hydroxide 12.01 
Sandia DF-200 9.95 
0.4% Oxy-Sept® 333 2.44 
1% Virkon® S 2.45 
  
Table 4.1 Average pH values for test disinfectants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 81
    BEV-2     FMDV   
Treatment 0%a 10% 50% 0% 10% 50% 
POSb 5.88 5.99 5.77 6.44 6.43 6.64 
AAc 4.66* 3.62 4.99 1.97 1.97 1.88 
BLCHd 1.80 1.80 1.80 1.88 1.88 2.05 
ETOHe 4.54 4.66 4.66 4.22 4.47 5.38 
NA2CO3f 3.55 3.25 3.10 2.13 2.20 1.80 
NAOHg 1.80 1.80 1.96 1.97 2.17 2.05 
DF-200h 1.80 1.80 1.80 1.80 1.80 1.80 
OXYSEPTi 1.85 2.88 2.77 2.63 2.30 1.88 
VIRKONj 1.80 1.80 1.85 1.97 2.13 1.80 
  
Table 4.2 Infectivity of BEV-2 and FMDV as measured by TCID50 following 10 min exposure 
to test disinfectants in the presence of test organic concentrations of bovine feces (0%, 10%, 
50%).  
 
a % Bovine feces 
b POS, Positive untreated control sample 
c AA, 5% acetic acid 
d BLCH, 10% bleach 
e ETOH, 70% ethanol 
f NA2CO3, 4% sodium carbonate 
g NAOH, 2% sodium hydroxide 
h DF-200, Sandia decon foam 
i OXYSEPT, 0.4% Oxy-Sept® 333 
j VIRKON, 1% Virkon® S 
 
* Bolded numbers are significantly different between BEV-2 and FMDV 
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    BEV-2     FMDV   
Treatment 0%a 10% 50% 0% 10% 50% 
POSb 6.33 5.99 6.25 6.44 6.43 6.64 
AAc 3.62* 3.73 3.52 1.80 1.80 1.80 
BLCHd 1.80 1.80 1.80 1.80 1.80 1.80 
ETOHe 4.61 4.88 4.88 4.22 6.97 5.55 
NA2CO3f 2.73 2.93 2.88 1.80 1.80 1.80 
NAOHg 1.80 1.80 1.96 1.80 1.80 1.80 
DF-200h 1.80 1.80 1.80 1.80 1.80 1.80 
OXYSEPTi 1.80 1.80 1.96 1.80 1.80 1.80 
VIRKONj 1.80 1.80 1.85 1.80 1.80 1.80 
  
Table 4.3 Infectivity of BEV-2 and FMDV as measured by TCID50 following 20 min exposure 
to test disinfectants in the presence of test organic concentrations of bovine feces (0%, 10%, 
50%). 
 
a % Bovine feces 
b POS, Positive untreated control sample 
c AA, 5% acetic acid 
d BLCH, 10% bleach 
e ETOH, 70% ethanol 
f NA2CO3, 4% sodium carbonate 
g NAOH, 2% sodium hydroxide 
h DF-200, Sandia decon foam 
i OXYSEPT, 0.4% Oxy-Sept® 333 
j VIRKON, 1% Virkon® S 
 
* Bolded numbers are significantly different between BEV-2 and FMDV 
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  BEV-2   FMDV   
Treatment 0%a 10% 0% 10%
POSb 5.48 5.65 6.43 7.91 
 
AAc 4.93 5.08 3.69 4.93 
BLCHd 2.33* 4.73 0.48 3.44 
ETOHe 5.24 5.11 6.63 6.76 
NA2CO3f 3.14 4.01 1.76 4.73 
NAOHg 1.59 2.22 0.00 4.45 
DF-200h 0.76 1.55 0.00 2.43 
OXYSEPTi 4.61 4.79 4.07 5.38 
VIRKONj 5.25 4.86 3.78 5.24 
  
Table 4.4 Amount of BEV-2 and FMDV RNA (log10) based on a standard curve generated from 
RNA extracted from predetermined levels of both viruses (quantified by TCID50) as measured by 
quantitative rRT-PCR following 10 min exposure to test disinfectants in the presence of test 
organic concentrations of bovine feces (0%, 10%, 50%).  
 
a % Bovine feces 
b POS, Positive untreated control sample 
c AA, 5% acetic acid 
d BLCH, 10% bleach 
e ETOH, 70% ethanol 
f NA2CO3, 4% sodium carbonate 
g NAOH, 2% sodium hydroxide 
h DF-200, Sandia decon foam 
i OXYSEPT, 0.4% Oxy-Sept® 333 
j VIRKON, 1% Virkon® S 
 
* Bolded numbers are significantly different between BEV-2 and FMDV 
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   BEV-2   FMDV   
Treatment 0%a 10% 0% 10% 
POSb 5.48 5.98 5.91 7.91 
AAc 5.11 4.94 5.39 5.37 
BLCHd 0.93 2.53 0.00 0.48 
ETOHe 5.76 5.26 6.63 7.23 
NA2CO3f 3.21 3.43 3.71 4.78 
NAOHg 0.00 1.89 0.37 4.45 
DF-200h 1.66 3.30 1.68 3.44 
OXYSEPTi 4.34 3.05 0.64 5.38 
VIRKONj 5.10 5.22 5.54 7.68 
  
Table 4.5 Amount of BEV-2 and FMDV RNA (log10) based on a standard curve generated from 
RNA extracted from predetermined levels of both viruses (quantified by TCID50) as measured by 
quantitative rRT-PCR following 20 min exposure to test disinfectants in the presence of test 
organic concentrations of bovine feces (0%, 10%, 50%).  
 
a % Bovine feces 
b POS, Positive untreated control sample 
c AA, 5% acetic acid 
d BLCH, 10% bleach 
e ETOH, 70% ethanol 
f NA2CO3, 4% sodium carbonate 
g NAOH, 2% sodium hydroxide 
h DF-200, Sandia decon foam 
i OXYSEPT, 0.4% Oxy-Sept® 333 
j VIRKON, 1% Virkon® S 
 
* Bolded numbers are significantly different between BEV-2 and FMDV 
 
 
 
 
 
 
 
 
 
 
 
 
 85
CHAPTER 5 - Inactivation of Foot and Mouth Disease Virus on 
Environmental Surfaces 
Abstract 
Foot and Mouth Disease virus (FMDV) is of great economic importance and highly 
contagious.  This virus is known to persist in the environment and survive on various surfaces for 
extended periods, making containment and eradication efforts difficult.  Chemical 
decontamination and restoration of contaminated facilities is necessary prior to the re-
introduction of susceptible animals.  The purpose of this study was to evaluate the virucidal 
efficacy of chemical biocides using US EPA testing guidelines against FMDV inoculated onto 
concrete, rubber, or stainless steel.  Experimental exposures (5, 10, 20 min) were evaluated with 
5% acetic acid, 10% bleach, 70% ethanol, 4% sodium carbonate, 2% sodium hydroxide, Sandia 
DF-200, 0.4% Oxy-Sept® 333, or 1% Virkon® S.  All treatments except 70% ethanol were 
effective under EPA requirements following 10 and 20 min contact on rubber and stainless steel.  
No treatments were shown to be effective under EPA requirements for concrete, due to a low 
recovery of virus from this surface.  Additionally, 10 and 20 min treatment with 10% bleach, 2% 
sodium hydroxide, and Sandia DF-200 were shown to degrade the viral nucleic acid (RNA) 
based on a quantitative rRT-PCR assay. 
Introduction 
Foot and Mouth Disease virus (FMDV), which infects cloven-hoofed animals, is 
considered one of the most infectious diseases known to exist and is undoubtedly one of the most 
economically important diseases (41).  Prospects for disease control include culling, slaughter, 
and vaccination to prevent the spread of virus by contact with infected animals, animal products, 
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fomites, or aerosol (46).  Decontamination and facility restoration of the contaminated premises 
during an FMDV outbreak would aid in disease containment and eradication and is required 
before naïve animals can be reintroduced.  
Two predominant methods for evaluating virucidal efficacy of disinfectants exist in the 
form of guidelines and include suspension and carrier tests (67, 75, 82).  Suspension tests 
evaluate the test virus as liquid inoculum while carrier tests are designed for evaluating virus 
inoculated and dried onto environmental surfaces (or carriers).  Existing efficacy literature 
specific for FMDV includes suspension and carrier based procedures, but is of limited value due 
to the inconsistent methodology and the majority of this information precedes the current 
virucidal standardization and guidelines existing for virucidal testing (8-11, 15, 24, 30, 34).  
Strong evidence exists to support the survival and persistence of FMDV in the environment and 
on various fomites (26, 37, 38, 42, 66, 71, 80, 89), further supporting the need to have carrier 
efficacy evaluations available for FMDV.  Literature also indicates that it is typically more 
difficult to decontaminate dried inoculum on surfaces when compared to the same inoculum in 
liquid suspension (82).   
The Klein and Deforest virus susceptibility scheme (47) is based predominantly on the 
physical features of viral groups, categorizing into enveloped, large non-enveloped, and small 
non-enveloped.  Limitations within this classification scheme exist, and viruses with similar 
grouping or even belonging to the same viral family do not always react similarly to chemical 
inactivation.  This was shown previously comparing efficacy between FMDV and bovine 
enterovirus, also a member of the Picornaviridae family (19).  Other factors, including biocide 
concentration, pH, contact time, and temperature should also be considered for more accurate 
predictions (56).  For surface disinfection, the ability of a disinfectant to adequately cover a 
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surface and maintain effectiveness in the presence of organic material is also very important for 
virucidal efficacy.     
The U. S. Environmental Protection Agency (EPA) has published guidelines for 
evaluating disinfectants for virucidal claims including both suspension and carrier assays (34). 
The guidelines require a modification of the AOAC Use-Dilution Method (6) which was 
prepared for bactericidal methodology, but provide very little information on the type of surface 
to be used, how long to allow the inoculum to dry, or how to remove cytotoxicity from the 
samples.  There is also no guidance on how to standardize the amount of virus or how much 
virus to inoculate a surface with, but a recoverable virus titer of at least 104 is required from non-
treated positive control samples.     
The purpose of this study was to evaluate the efficacy of standard and novel chemistries 
against FMDV inoculated onto environmental surfaces following the current EPA guidelines.  
Virus was enumerated by a quantitative recovery of infectious titer (as determined by tissue 
culture infective dose 50) or by a quantitative real-time reverse transcriptase polymerase chain 
reaction (rRT-PCR) assay specific for FMDV.  In both recovery systems, statistical analysis was 
conducted to determine if the disinfectant treatment resulted in significant reduction in viral titer 
when compared to non-treated positive control samples.  Chemical biocides used in this study 
included acetic acid, bleach, ethanol, sodium carbonate, sodium hydroxide, and novel 
chemistries including Sandia DF-200 (91), Oxy-Sept® 333 (2), and Virkon® S (5) previously 
evaluated in a suspension based study (19).  Experimental surfaces included concrete, rubber, 
and stainless steel and were exposed for 5, 10 or 20 min.   
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Materials and Methods 
Virus and cells.  FMDV type O1 strain Brugge was propagated in Baby Hamster Kidney 
21 (BHK-21, ATCC CCL-10) cells as previously described (19).   BHK-21 cells were 
maintained in minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS 
adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM 
sodium pyruvate with 10% fetal bovine serum (FBS, Hyclone Laboratories, Logan, UT) 
supplemented with antibiotics previously described (19).  FMDV titer was determined using 
tissue culture infective dose 50, TCID50 and calculated by the Reed-Muench method (74).   
Test Disinfectants. Test disinfectants were prepared as previously described (19) and 
included the following: 5% acetic acid, 10% bleach, 70% ethanol, 4% sodium carbonate, 2% 
sodium hydroxide, 100% Sandia DF-200, 0.4% Oxy-Sept® 333, and 1% Virkon® S.  Test 
disinfectants were prepared fresh each time prior to use.  The pH values were measured and 
recorded prior to use to ensure proper mixing.         
Test Surfaces. Test surfaces included concrete, rubber, and stainless steel.  Quikcrete 
(The Home Depot, Albuquerque, NM) was purchased and mixed according to the manufacturer’s 
instructions.  Sterile 50 ml conical tubes (Fischer, Hampton, NH) were filled with the Quikcrete 
mixture to approximately the 10 ml volume.  Samples were dried in a sterile hood for 
approximately 30 days.  Prior to use, samples were exposed to a UV light in a sterile hood for 1 
hour.  Butyl rubber sheets (McMaster Carr, Atlanta, GA) were cut into round coupons having a 
surface area of 4.15 cm2.  Stainless steel type 304 sheets (McMaster Carr) were cut into round 
coupons having a surface area of 4.15 cm2.  The rubber and stainless steel coupons were 
autoclaved prior to use.  
Virus Inactivation. Test coupons were inoculated with 100 µl FMDV (propagated to 
approximately 107 in BHK-21 cells) and dried in a sterile biosafety class II cabinet for 
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approximately 30 min.  After samples were completely dried, 500 µl test disinfectant (or MEM 
containing 4% FBS for non-treated positive control samples) was added to each surface and 
exposed for 5, 10 or 20 min.  Following exposure, surfaces were transferred to sterile 50 ml 
conical tubes and 5 ml MEM containing 4% FBS was added.  Samples were vortexed for 1 min 
to release virus from surface.  
Post-treatment Recovery of Infectious Virus.  The titers of infectious virus were 
determined as TCID50 in cell culture using a 96-well format as previously described (19).  
TCID50 was determined visually by evaluating cytopathic effect (CPE) typical for FMDV as 
indicated by the presence of rolling or sloughing of infected cells.  TCID50 titer was determined 
using the Reed-Muench method for estimating endpoints (74).    
Post-treatment Recovery of FMDV RNA using rRT-PCR. FMDV RNA was 
recovered using the RNeasy Kit (Qiagen, Valencia, CA) and quantitative detection of the 
extracted RNA was conducted using rRT-PCR assay as previously described (19).  The rRT-
PCR primer and probe sequence for FMDV was obtained from Callahan et al, 2002 (21).  A 
standard curve was generated using the SmartCycler® using purified FMDV RNA from a 
predetermined amount of infectious FMDV (determined by TCID50).  The slope of the standard 
curve generated was calculated and used to quantify the amount of viral RNA recovered post-
treatment.  Post-treated viral RNA was recovered from the test samples using the RNeasy Mini 
Kit.  Quantitative detection of the RNA was determined by a FAM fluorescence signal ≥ 3 using 
the SmartCycler® using rRT-PCR.   
Statistical Analysis. An analysis to assess the statistical differences in the level of virus 
recovered by TCID50 or by quantitative rRT-PCR following the experimental treatment 
parameters was carried out by comparing 1-way, 2-way, and 3-way interactions between 
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disinfectant treatments, time.  The least square of means was calculated to determine if 
significant differences were observed in amount of infectious virus or viral RNA recovered 
compared to non-treated positive control samples.  A significant difference between treatments is 
inferred with a P-value ≤ 0.05.   
Results 
Post-treatment Recovery of Infectious Virus.  The average infectious titer recovered 
from the test surfaces was 4.83, 6.17, or 6.25 log10 TCID50/ml for concrete, rubber, or stainless 
steel, respectively (Figure 5.1- 5.3).  Effective disinfectant treatments were inferred by 
observations of a statistically significant reduction (P ≤ 0.05) in infectious titer of each test virus 
when compared to the non-treated positive control sample and must be ≥ 4.0 log10 TCID50/ml to 
meet the EPA requirement for virucidal efficacy claims.  If no infectious virus could be 
recovered in the TCID50 assay based on the absence of CPE, then the detection limit of the assay 
was reported (1.75 log10 TCID50 which equals 28.36% of viable virus).   
Following 5 min exposure with the test biocides, there were no effective treatments for 
FMDV resulting in a ≥ 4.0 log10 reduction in titer on any of the test surfaces.  Most treatments 
resulted in the recovery of approximately 40-53% viable virus, while 70% ethanol resulted in the 
recovery of 81-100% viable virus for all surfaces evaluated (Figure 5.1).   
Following 10 min exposure with the test biocides, there were no effective treatments for 
FMDV resulting in a ≥ 4.0 log10 reductions in titer on concrete, as the positive control sample 
was not greater than 4.0 log10 above the detection limit of the assay (1.75 log10 TCID50).  Most 
treatments resulted in the recovery of approximately 44-53% viable virus, while 70% ethanol 
resulted in the recovery of 84% viable virus (Figure 5.2).  Effective treatments (P ≤ 0.05) for 
FMDV resulting in a ≥ 4.0 log10 reductions in titer on rubber and stainless steel included all 
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disinfectants evaluated except for 70% ethanol, which resulted in the recovery 93-100% viable 
virus (Figure 5.2).   
Following 20 min exposure with the test biocides, there were no effective treatments for 
FMDV resulting in a ≥ 4.0 log10 reductions in titer on concrete, as the positive control sample 
was not greater than 4.0 log10 above the detection limit of the assay (1.75 log10 TCID50).  Most 
treatments resulted in the recovery of approximately 34-41% viable virus, while 70% ethanol 
resulted in the recovery of 82% viable virus (Figure 5.3).  Effective treatments (P ≤ 0.05) for 
FMDV resulting in a ≥ 4.0 log10 reductions in titer on rubber and stainless steel included all 
disinfectants evaluated except for 70% ethanol, which resulted in the recovery 88-91% viable 
virus (Figure 5.3).   
Post-treatment Recovery of FMDV RNA using rRT-PCR. The average amount of 
FMDV RNA recovered from the test surfaces was 3.95, 6.06, or 6.14 log10 RNA copies per 
TCID50/ml for concrete, rubber, or stainless steel, respectively (Tables 5.1-5.3).  Effective 
disinfectant treatments were inferred by observations of a statistically significant reduction (P ≤ 
0.05) in FMDV RNA when compared to the non-treated positive control sample.   
Following 5 min exposure (Table 5.1), effective treatments for degrading FMDV RNA 
on concrete were 10% bleach and Sandia DF-200.  The other disinfectants resulted in the 
recovery of 31-46% of the viral RNA.   The only effective treatment following 5 min exposure 
for degrading FMDV RNA on rubber was 2% sodium hydroxide.  The remaining test treatments 
resulted in the recovery of 42-95% of the viral RNA.  Effective treatments following 5 min 
exposure for degrading FMDV RNA on stainless steel included 10% bleach, 2% sodium 
hydroxide, and Sandia DF-200.   The remaining test treatments resulted in the recovery of 43-
62% of the viral RNA.   
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Following 10 min exposure (Table 5.2), effective treatments for degrading FMDV RNA 
on concrete were 10% bleach, 4% sodium carbonate and Sandia DF-200.  The other disinfectants 
resulted in the recovery of 40-100% of the viral RNA.   Effective treatments following 10 min 
exposure for degrading FMDV RNA on rubber included 10% bleach, 2% sodium hydroxide, and 
Sandia DF-200.  The remaining test treatments resulted in the recovery of 41-96% of the viral 
RNA.  Effective treatments following 10 min exposure for degrading FMDV RNA on stainless 
steel included 10% bleach, 2% sodium hydroxide, Sandia DF-200, 0.4% Oxy-Sept® 333, and 
1% Virkon® S.   The remaining test treatments resulted in the recovery of 66-93% of the viral 
RNA.   
Following 20 min exposure (Table 5.3), effective treatments for degrading FMDV RNA 
on concrete included all treatments except 1% Virkon® S, which resulted in the recovery of 66% 
of the viral RNA.   Effective treatments following 10 min exposure for degrading FMDV RNA 
on rubber included 10% bleach, 2% sodium hydroxide, Sandia DF-200, 0.4% Oxy-Sept® 333, 
and 1% Virkon® S.  The remaining test treatments resulted in the recovery of 42-100% of the 
viral RNA.  Effective treatments following 10 min exposure for degrading FMDV RNA on 
stainless steel included 10% bleach, 4% sodium carbonate, 2% sodium hydroxide, Sandia DF-
200, 0.4% Oxy-Sept® 333, and 1% Virkon® S.   The remaining test treatments resulted in the 
recovery of 77-89% of the viral RNA.   
Discussion  
Due to the persistence and stability of FMDV on various fomites and in the environment, 
the purpose of this study was to evaluate the efficacy of standard and novel chemistries against 
FMDV inoculated onto environmental surfaces.  Virus was enumerated by a quantitative 
recovery of infectious titer (as determined by tissue culture infective dose 50) or by a 
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quantitative real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay specific 
for FMDV.  In both recovery systems, statistical analysis was conducted to determine if the 
disinfectant treatment resulted in significant reduction in viral titer when compared to non-
treated positive control samples.  No effective treatments were observed on concrete surfaces for 
any of the time exposures evaluated.  Effective treatments against FMDV resulting in a ≥ 4.0 
log10 reduction in titer on rubber and stainless steel included all disinfectants evaluated except for 
70% ethanol following 10 and 20 min exposure.  The amount of viral RNA that was degraded 
varied depending on the test surface, but treatment with 10% bleach, 2% sodium hydroxide or 
Sandia DF-200 resulted in significant reductions following 10 or 20 min treatment. 
The selection of the test surfaces used in this study was to include materials (both porous 
and non-porous) commonly found in an agriculture setting.  It is generally accepted that 
inanimate surfaces can play an important role in disease transmission, especially in the case of a 
highly infectious and persistent virus such as FMDV (71).  Decontamination of contaminated 
surfaces such as animal pens, vehicles, equipment, and even personnel (71, 75) is necessary for 
disruption the transmission cycle of FMDV to aid in disease containment. 
Efficacy results generated in this study for FMDV were similar to those generated in a 
similar study based on suspension tests (19), although 5 min contact times were not previously 
evaluated.  In both studies, FMDV was inactivated by all treatments except for 70% ethanol 
following 10 min exposure.  In the current study, most treatments (except 70% ethanol) resulted 
in a 50% reduction in titer following 5 min exposure.  The drying step resulted in approximately 
a 1.0 log10 reduction in starting titer on rubber and stainless steel, and approximately a 2.5 log10 
reduction in titer onto concrete.  It is common for some virus to be lost in the drying step for 
carrier assays (56, 61, 69, 75).   The amount of virus recovered from concrete was 
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consistently lower than the amount recovered from rubber and stainless steel.  This is most likely 
due to the cytotoxicity occurring due to both the high pH (approximately 11) of the concrete and 
the particulate debris releasing from the surface during the sample vortexing step.  In many 
cases, the amount of virus recovered from the concrete was not more than a 4.0 log10 amount 
over the assay detection limit of 1.75 log10, making the ≥ 4.0 log10 reduction in titer impossible to 
achieve.  The amount of viral RNA recovered from the concrete surface was also lower than that 
recovered from rubber and stainless steel.  This could be explained in two ways.  In the first 
example, virus particles are more protected in the rough surface of this material, and are more 
difficult to recover.  The second possibility is likely due to a low level inhibition of the rRT-PCR 
assay occurring from the relatively basic pH of this material, and the presence of particulates in 
the sample solution post-vortexing.     
Following the longer time exposures evaluated (10 or 20 min) efficacy results obtained 
from rubber and stainless steel were very similar and appeared to be easier to decontaminate than 
concrete.  Concrete was consistently the most difficult surface to effectively decontaminate, 
probably due to the very rough surface associated with this material.  The cracks and pores could 
potentially serve as physical barrier preventing the necessary contact of the test disinfectants to 
the virus targets.  Viruses, especially the picornaviruses, which are approximately 30 nm in 
diameter (65), can be protected in scratches or imperfections on a surface (75, 82).  The 
smoother surfaces of the rubber and stainless steel carriers were probably easier for the test 
disinfectants to penetrate and interact with the viral targets.      
In conclusion, several disinfectants were found to be effective for inactivating FMDV 
following the current EPA guidelines for virucidal efficacy requirements resulting in a ≥ 4.0 
log10 reduction in titer on various environmental surfaces.  Effective treatments against FMDV 
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on rubber and stainless steel included all disinfectants evaluated except for 70% ethanol 
following 10 and 20 min exposure.  No effective treatments (by US EPA definition) were 
observed on concrete surfaces mostly because the amount of non-treated positive control virus 
recovered was very low.  The difference in the amount of positive control virus recovered and 
the detection limit of the assay was not greater than 4.0 log10, so it was impossible to achieve the 
required reduction in titer.  The amount of viral RNA recovered from the test surfaces was 
lowest from concrete samples and higher from rubber and stainless steel.  In general, treatment 
with 10% bleach, 2% sodium hydroxide or Sandia DF-200 resulted in a significant reduction in 
the amount of FMDV RNA following 10 or 20 min treatment and correlated with results 
obtained from TCID50. 
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Figure 5.1 The fraction of viable FMDV (%) as recovered by TCID50 following 5 min exposure 
to test disinfectants on test surfaces.   
 
Error bars indicate 1 standard deviation (n = 3).   AA, 5% acetic acid; BLCH, 10% bleach; 
ETOH, 70% ethanol; NA2CO3, 4% sodium carbonate; NAOH, 2% sodium hydroxide; DF-200, 
Sandia Decon Foam; OXYSEPT, 0.4% Oxy-Sept® 333; VIRKON, 1% Virkon® S. 
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Figure 5.2 The fraction of viable FMDV (%) as recovered by TCID50 following 10 min exposure 
to test disinfectants on test surfaces.   
 
Error bars indicate 1 standard deviation (n = 3).   AA, 5% acetic acid; BLCH, 10% bleach; 
ETOH, 70% ethanol; NA2CO3, 4% sodium carbonate; NAOH, 2% sodium hydroxide; DF-200, 
Sandia Decon Foam; OXYSEPT, 0.4% Oxy-Sept® 333; VIRKON, 1% Virkon® S. 
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Figure 5.3 The fraction of viable FMDV (%) as recovered by TCID50 following 20 min exposure 
to test disinfectants on test surfaces.   
 
Error bars indicate 1 standard deviation (n = 3).   AA, 5% acetic acid; BLCH, 10% bleach; 
ETOH, 70% ethanol; NA2CO3, 4% sodium carbonate; NAOH, 2% sodium hydroxide; DF-200, 
Sandia Decon Foam; OXYSEPT, 0.4% Oxy-Sept® 333; VIRKON, 1% Virkon® S. 
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 Treatment Concrete Rubber Stainless steel 
AAa 36.57 59.70 61.98 
BLCHb 0.00 85.41 22.15 
ETOHc 38.23 95.19 99.17 
NA2CO3d 31.02 44.44 47.11 
NAOHe 31.02 0.00 19.01 
DF-200f 0.00 42.29 20.83 
OXYSEPTg 45.71 68.66 51.07 
VIRKONh 31.02 50.58 42.98 
  
Table 5.1 The percentage of FMDV RNA as recovered by quantitative rRT-PCR following 5 
min exposure to test disinfectants on test surfaces.   
 
a AA, 5% acetic acid 
b BLCH, 10% bleach 
c ETOH, 70% ethanol 
d NA2CO3, 4% sodium carbonate 
e NAOH, 2% sodium hydroxide 
f DF-200, Sandia decon foam 
g OXYSEPT, 0.4% Oxy-Sept® 333 
h VIRKON, 1% Virkon® S 
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 Treatment Concrete Rubber Stainless steel 
AAa 70.22 88.37 86.02 
BLCHb 0.00 44.03 16.74 
ETOHc 111.86 95.97 93.39 
NA2CO3d 0.00 73.33 65.59 
NAOHe 40.19 17.21 34.41 
DF-200f 0.00 40.93 25.35 
OXYSEPTg 92.98 53.18 35.18 
VIRKONh 67.07 42.02 35.64 
  
Table 5.2 The percentage of FMDV RNA as recovered by quantitative rRT-PCR following 10 
min exposure to test disinfectants on test surfaces.   
 
a AA, 5% acetic acid 
b BLCH, 10% bleach 
c ETOH, 70% ethanol 
d NA2CO3, 4% sodium carbonate 
e NAOH, 2% sodium hydroxide 
f DF-200, Sandia decon foam 
g OXYSEPT, 0.4% Oxy-Sept® 333 
h VIRKON, 1% Virkon® S 
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 Treatment Concrete Rubber Stainless steel 
AAa 28.22 84.56 77.44 
BLCHb 33.58 21.75 0.00 
ETOHc 34.31 107.02 88.72 
NA2CO3d 28.22 41.93 18.46 
NAOHe 0.00 0.00 0.00 
DF-200f 0.00 0.00 0.00 
OXYSEPTg 36.98 24.39 19.32 
VIRKONh 65.94 0.00 0.00 
  
Table 5.3 The percentage of FMDV RNA as recovered by quantitative rRT-PCR following 20 
min exposure to test disinfectants on test surfaces.   
 
a AA, 5% acetic acid 
b BLCH, 10% bleach 
c ETOH, 70% ethanol 
d NA2CO3, 4% sodium carbonate 
e NAOH, 2% sodium hydroxide 
f DF-200, Sandia decon foam 
g OXYSEPT, 0.4% Oxy-Sept® 333 
h VIRKON, 1% Virkon® S 
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CHAPTER 6 - Conclusions 
In order to increase insight into the overall efficacy and mechanism for virucidal 
inactivation by chemical biocides, several studies were conducted using different types of 
viruses.  It is widely recognized that different types of viruses vary with regard to their 
susceptibility to chemical inactivation and have been well characterized by Klein and Deforest 
(47).  The US EPA has a published set of guidelines for producing virucidal efficacy claims on 
chemical disinfectants (34).  Among these virucidal guidelines, information regarding initial 
review and labeling of the disinfectant, efficacy data requirements, and confirmatory efficacy 
requirements are all included.  Under the efficacy data requirements for virucidal efficacy 
claims, it is recommended that a recoverable virus titer of at least 104 reported as infective dose 
50 (ID50) of the test system should be recovered from non-treated positive control samples.  The 
ID50 assay used must have a minimum of four determinations per each dilution of test sample 
and cytoxicity controls must be included.  For the disinfectant to be accepted as virucidal, the 
product should demonstrate complete inactivation at all dilutions.  In the case of cytoxicity, a 3-
log reduction in titer must be demonstrated beyond the cytotoxic level.  The claim of virucidal 
efficacy is restricted to the virus which is evaluated, except in the case of the EPA accepted 
surrogate test viruses.  It is unclear as to whether such claims can only be made with that 
particular isolate or the viral family in general. 
In the first study conducted using bovine coronavirus and described in Chapter 2, the US 
EPA guidelines were followed to generate the virucidal efficacy data and also included two 
different types of organic challenge, which aren’t required in the existing guidelines.  The 
greatest challenge in this evaluation was cytotoxicity resulting from the chemical disinfectants in 
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the infectivity assay (TCID50).  The addition of an ultracentrifugation step in the methodology to 
purify the virus and remove the chemical component of the samples resulted in the removal of 
cytotoxicity for most disinfectants evaluated (except for DF-200d and Virkon® S).  Although the 
DF-200d and Virkon® S were cytotoxic even post-ultracentrifugation, most of the cytoxicity 
was removed and all dilutions beyond the first serial 1:10 dilution for both of these disinfectants 
were non-cytotoxic and fulfilled the requirements of the EPA guidelines “showing a minimum of 
a 3-log reduction in titer beyond the cytotoxic level” (34).   
The coronavirus study also evaluated the sensitivities of existing diagnostic assays for 
potential use to evaluate the efficacy of chemical disinfectants.  Although ID50 assays are 
required in the EPA guidelines, other assays can enhance the overall data by providing insight 
into the possible mechanism of inactivation.  For example, the use of a diagnostic assay 
depending on the presence of nucleic acid could show if any degradation to this target was 
occurring.  This could also be determined using a diagnostic assay depending on the presence of 
a structural protein receptor or capsid.  Quantitative RT-PCR was found to be the most sensitive 
for determining the mechanism of action while the detection of structural proteins could only be 
included qualitatively and suffered in being less sensitive.           
The second set of virucidal efficacy testing conducted in this research is described in 
Chapter 3 comparing a mammalian influenza A virus to an avian influenza A virus. The use of 
surrogate viruses for efficacy testing are a result of the Klein and Deforest susceptibility 
predictions (47) are the basis for the accepted surrogate viruses by the US EPA and is published 
in their current virucidal efficacy testing guidelines (34).  Most of these accepted surrogates are 
the result of not having a cultivation method for the virus of interest, so a closely related 
surrogate virus is evaluated instead on the assumption that they will react similarly.  Due to the 
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emergence of highly pathogenic and infectious diseases such as the highly pathogenic avian 
influenza, H5N1 or the threat of non-endemic diseases such as FMDV, which are not privy for 
cultivation in standard virology laboratories, the use of closely related surrogate viruses could 
result in the safe generation of efficacy data following the EPA guidelines under BSL-2 
containment.  In Chapter 3 efficacy results obtained for two closely related viruses, mammalian 
H1N1 and a low pathogenic avian H5N8 isolate, did not show any significantly different 
observations, suggesting that one influenza A virus could be a surrogate testing virus for another 
influenza A virus.  This is an important finding as the US EPA is accepting the use of efficacy 
data for any avian influenza A virus to be applied to the H5N1 isolate (3), even though this has 
not been previously validated in existing literature.   
Although the Klein and Deforest prediction scheme suggests that viruses among the same 
family will react similarly to chemical disinfectants, there are some examples in which this does 
not occur.  An example of this is described in Chapter 4 comparing the virucidal efficacy of 
different disinfectant chemistries between FMDV and BEV-2, both members of the 
Picornaviridae family.  Because BEV-2 and other enteroviruses in this family are enteric, they 
must remain viable in acidic environments to remain infectious.  Viruses such as FMDV, 
although physically similar, do not require this resistance and were very susceptible to 
inactivation by acidic compounds.  This outcome emphasizes the importance for not only 
considering the physical properties of a virus, but also the factors necessary for their infectious 
cycle, such as an acid resistance mechanism which might result in very different susceptibilities 
to chemical disinfectants. 
The final study conducted and described in Chapter 5 was evaluating the inactivation of 
FMDV on environmental surfaces including concrete, rubber, and stainless steel.  The current 
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US EPA virucidal efficacy testing guidelines recommend that disinfectants for use on surfaces 
should be evaluated using carrier tests and reference the AOAC Use-Dilution Method (6), which 
was actually prepared for bacterial agents.  There is no guidance on how much virus to inoculate 
the surfaces with, or how to standardize the titer among various surfaces.  The guidelines require 
a recoverable virus titer of at least 104 log10 TCID50 from each surface for non-treated positive 
control samples.  In our study, we determined that inoculating the 4.15 cm2 surfaces with 100 µl 
FMDV (at a starting titer of 107-8 TCID50/ml) resulted in the consistent recovery of > 104 log 
virus titer for each surface. The drying step resulted in approximately a 1.0 log10 reduction in 
starting titer on rubber and stainless steel, and approximately a 2.5 log10 reduction in titer onto 
concrete and is common for some infectivity to be lost during the drying step (56, 61, 69, 75).  
Overall, the surface results were very similar to the suspension results described in Chapter 4.  
Most treatments, except for 70% ethanol, resulted in a greater than 4.0 log10 reduction in titer.  
Based on the results obtained from all of these studies, some general conclusions and 
next steps can be summarized.  Enveloped viruses including corona and influenza A viruses 
evaluated were much less resistant than the non-enveloped picornaviruses evaluated in the 
various studies, and was consistent with the Klein and Deforest virus prediction scheme (47).  In 
one case, two viruses within the same viral family (FMDV and BEV-2, Picornaviridae) were 
shown to have different susceptibility to acidic compounds, due largely on differences with 
regard to their infectious life cycle.  All tests conducted followed the current US EPA guidelines 
for evaluating virucidal efficacy of chemical biocides.  Cytotoxicity from the active chemicals in 
the disinfectants was the greatest challenge in the recovery assay to determine how much 
infectious virus was remaining.  Cytotoxicity was significantly reduced by an ultracentrifugation 
step, and allowed the successful recovery of viable virus from each disinfectant evaluated.  The 
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use of rRT-PCR assays for all test viruses provided insight into the mechanism of action 
occurring from degradation of RNA for some of the chemical biocides used, and could be used 
as a rapid assay for verifying loss of infectivity for these disinfectants.  The biocides which did 
not show degradation of RNA most likely functioned by disruption of other viral targets such as 
the envelope (if present) or viral proteins.  Both of these mechanisms likely prevent the 
attachment and entry of a virus particle into a cell resulting in the successful disruption of the 
transmission cycle.     
In closing, these results show the importance for validating chemical disinfectants for 
virucidal efficacy against different groups of virus.  As a current member of a working group 
with the US EPA, which also includes representatives from the U. S. Department of Agriculture 
(USDA), the Food and Drug Administration (FDA), the U. S. Department of Homeland Security 
(DHS), there is a strong need to standardize the current guidelines required for obtaining 
virucidal efficacy labeling claims.  Such standards are already in place with the EPA for 
bactericidal, sporicidal, fungicidal, and other microbiocidal claims.  Based on the results from 
the experiments in this study, I feel that there are a few issues which should be addressed for a 
standardized protocol.  The current process requires the validation of every virus for which a 
claim is to be made.  During an ongoing outbreak, it might be very difficult to generate such 
efficacy data, so perhaps the evaluation of several viruses representing the various groups of 
viruses likely to differ in susceptibility (according to Klein and Deforest classification) should be 
required to be evaluated in the standardized protocol.  Specific detail including disinfectant 
concentration, exposure length, relative humidity, temperature, and organic challenge would all 
be included.  Cytotoxicity controls would also be included for each host tissue culture required in 
the recovery process.  Additionally, specific surfaces for carrier assays would be identified and 
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information regarding the volume of inoculum and time for drying would be specified to 
standardize the assay for all viruses evaluated.  Having a set of standardized test viruses would 
provide useful data for chemical disinfectants and could be generalized with regard to efficacy 
for a particular virus in the case of an outbreak until specific efficacy data could be generated.  
This would be possible as long as the required standard viruses adequately represented the major 
groups among viruses.  The standardized testing would also be useful for biosafety 
decontamination procedures in biological containment laboratories to ensure that viruses used in 
such facilities are being effectively inactivated. 
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